CD14	B-protein
-mediated	O
translocation	O
of	O
nuclear	B-protein
factor-kappa	I-protein
B	I-protein
induced	O
by	O
lipopolysaccharide	O
does	O
not	O
require	O
tyrosine	B-protein
kinase	I-protein
activity	O
.	O

During	O
the	O
course	O
of	O
serious	O
bacterial	O
infections	O
,	O
lipopolysaccharide	O
(	O
LPS	O
)	O
is	O
believed	O
to	O
interact	O
with	O
macrophage	B-protein
receptors	I-protein
,	O
resulting	O
in	O
the	O
generation	O
of	O
inflammatory	O
mediators	O
and	O
systemic	O
symptoms	O
including	O
hemodynamic	O
instability	O
and	O
shock	O
.	O

CD14	B-protein
,	O
a	O
glycosylphosphatidylinositol-linked	B-protein
antigen	I-protein
,	O
functions	O
as	O
an	O
LPS	B-protein
signaling	I-protein
receptor	I-protein
.	O

A	O
critical	O
issue	O
concerns	O
the	O
mechanism	O
by	O
which	O
CD14	B-protein
,	O
which	O
has	O
no	O
transmembrane	B-protein
domain	I-protein
,	O
transduces	O
its	O
signal	O
following	O
LPS	O
binding	O
.	O

Recently	O
,	O
investigators	O
have	O
hypothesized	O
that	O
CD14	B-protein
-mediated	O
signaling	O
is	O
effected	O
through	O
a	O
receptor-associated	O
tyrosine	B-protein
kinase	I-protein
(	O
TK	O
)	O
,	O
suggesting	O
a	O
multicomponent	O
receptor	O
model	O
of	O
LPS	O
signaling	O
.	O

Wild-type	O
Chinese	B-cell_line
hamster	I-cell_line
ovary	I-cell_line
(	I-cell_line
CHO	I-cell_line
)	I-cell_line
-K1	I-cell_line
cells	I-cell_line
can	O
be	O
activated	O
by	O
endotoxin	O
to	O
release	O
arachidonate	O
following	O
transfection	O
with	O
human	O
CD14	B-protein
(	O
CHO/CD14	B-protein
)	O
.	O

Nuclear	O
translocation	O
of	O
cytosolic	O
NF-kappa	O
B	O
is	O
correlated	O
with	O
a	O
number	O
of	O
LPS-inducible	O
responses	O
.	O

We	O
sought	O
to	O
determine	O
if	O
this	O
pathway	O
were	O
present	O
in	O
CHO/CD14	B-cell_line
cells	I-cell_line
and	O
to	O
elucidate	O
the	O
relationship	O
of	O
NF-kappa	B-protein
B	I-protein
activation	O
to	O
the	O
CD14	B-protein
receptor	O
system	O
.	O

LPS-stimulated	O
translocation	O
of	O
NF-kappa	B-protein
B	I-protein
in	O
CHO/CD14	B-cell_line
cells	I-cell_line
resembled	O
the	O
same	O
response	O
in	O
the	O
murine	B-cell_line
macrophage-like	I-cell_line
cell	I-cell_line
line	I-cell_line
RAW	B-cell_line
264.7	I-cell_line
.	O

Protein	O
synthesis	O
inhibitors	O
and	O
corticosteroids	O
,	O
which	O
suppress	O
arachidonate	O
release	O
and	O
the	O
synthesis	O
of	O
proinflammatory	B-protein
cytokines	I-protein
,	O
had	O
no	O
effect	O
on	O
translocation	O
of	O
NF-kappa	B-protein
B	I-protein
in	O
CHO/	O
CD14	B-protein
or	O
RAW	B-cell_line
264.7	I-cell_line
cells	I-cell_line
,	O
demonstrating	O
that	O
NF-kappa	B-protein
B	I-protein
translocation	O
is	O
an	O
early	O
event	O
.	O

Although	O
TK	O
activity	O
was	O
consistently	O
observed	O
by	O
immunoblotting	O
extracts	O
from	O
activated	O
RAW	B-cell_line
264.7	I-cell_line
cells	I-cell_line
,	O
LPS-induced	O
phosphotyrosine	O
residues	O
were	O
not	O
observed	O
from	O
similarly	O
treated	O
CHO/CD14	B-cell_line
cells	I-cell_line
.	O

Furthermore	O
,	O
the	O
TK	O
inhibitors	O
herbimycin	O
A	O
and	O
genistein	O
failed	O
to	O
inhibit	O
translocation	O
of	O
NF-kappa	B-protein
B	I-protein
in	O
CHO/CD14	B-cell_line
or	O
RAW	B-cell_line
264.7	I-cell_line
cells	I-cell_line
,	O
although	O
both	O
of	O
these	O
agents	O
inhibited	O
LPS-induced	O
TK	O
activity	O
in	O
RAW	B-cell_line
264.7	I-cell_line
cells	I-cell_line
.	O

These	O
results	O
imply	O
that	O
TK	O
activity	O
is	O
not	O
obligatory	O
for	O
CD14	B-protein
-mediated	O
signal	O
transduction	O
to	O
occur	O
in	O
response	O
to	O
LPS	O
.	O

Trg	NULL
Journat	NULL
or	NULL
Biotocicat	NULL
Vol	NULL
.	NULL

269	NULL
,	NULL
No	NULL
.	NULL

35	NULL
,	NULL
Issue	NULL
of	NULL
September	NULL
2	NULL
,	NULL
pp	NULL
.	NULL

22253-22260	NULL
,	NULL
1994	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
CD14-mediated	NULL
Translocation	NULL
of	NULL
Nuclear	NULL
Factor-	NULL
«	NULL
B	NULL
Induced	NULL
by	NULL
Lipopolysaccharide	NULL
Does	NULL
Not	NULL
Require	NULL
Tyrosine	NULL
Kinase	NULL
Activity*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
March	NULL
22	NULL
,	NULL
1994	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
June	NULL
21	NULL
,	NULL
1994	NULL
)	NULL
Russell	NULL
L.	NULL
Deludet	NULL
{	NULL
I	NULL
}	NULL
,	NULL
Matthew	NULL
J.	NULL
FentonY	NULL
,	NULL
Ricardo	NULL
Savedra	NULL
,	NULL
Jr.	NULL
}	NULL
,	NULL
Pin-Yu	NULL
Perera**	NULL
,	NULL
Stefanie	NULL
N.	NULL
Vogel**	NULL
,	NULL
Rolf	NULL
Thieringert	NULL
}	NULL
,	NULL
and	NULL
Douglas	NULL
T.	NULL
Golenbock	NULL
#	NULL
M	NULL
From	NULL
the	NULL
{	NULL
Maxwell	NULL
Finland	NULL
Laboratories	NULL
for	NULL
Infectious	NULL
Diseases	NULL
,	NULL
Boston	NULL
City	NULL
Hospital	NULL
,	NULL
the	NULL
Research	NULL
Immunology	NULL
Section	NULL
and	NULL
the	NULL
§Department	NULL
of	NULL
Medicine	NULL
,	NULL
Boston	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02118	NULL
,	NULL
the	NULL
**Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Uniformed	NULL
Services	NULL
University	NULL
of	NULL
the	NULL
Health	NULL
Sciences	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20814	NULL
,	NULL
and	NULL
the	NULL
{	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Merck	NULL
Research	NULL
Laboratories	NULL
,	NULL
Rahway	NULL
,	NULL
New	NULL
Jersey	NULL
07065	NULL
During	NULL
the	NULL
course	NULL
of	NULL
serious	NULL
bacterial	NULL
infections	NULL
,	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
is	NULL
believed	NULL
to	NULL
interact	NULL
with	NULL
macrophage	NULL
receptors	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
inflammatory	NULL
mediators	NULL
and	NULL
systemic	NULL
symptoms	NULL
including	NULL
hemodynamic	NULL
instability	NULL
and	NULL
shock	NULL
.	NULL

CD14	NULL
,	NULL
a	NULL
glycosylphosphatidylinositol-linked	NULL
antigen	NULL
,	NULL
functions	NULL
as	NULL
an	NULL
LPS	NULL
signaling	NULL
receptor	NULL
.	NULL

A	NULL
critical	NULL
issue	NULL
concerns	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
CD14	NULL
,	NULL
which	NULL
has	NULL
no	NULL
transmembrane	NULL
domain	NULL
,	NULL
transduces	NULL
its	NULL
signal	NULL
following	NULL
LPS	NULL
bind-ing	NULL
.	NULL

Recently	NULL
,	NULL
investigators	NULL
have	NULL
hypothesized	NULL
that	NULL
CD14-mediated	NULL
signaling	NULL
is	NULL
effected	NULL
through	NULL
a	NULL
receptor-associated	NULL
tyrosine	NULL
kinase	NULL
(	NULL
TK	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
multicom-ponent	NULL
receptor	NULL
model	NULL
of	NULL
LPS	NULL
signaling	NULL
.	NULL

Wild-type	NULL
Chinese	NULL
hamster	NULL
ovary	NULL
(	NULL
CHO	NULL
)	NULL
-K1	NULL
cells	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
endotoxin	NULL
to	NULL
release	NULL
arachidonate	NULL
following	NULL
transfection	NULL
with	NULL
human	NULL
CD14	NULL
(	NULL
CHO/CD14	NULL
)	NULL
.	NULL

Nuclear	NULL
translocation	NULL
of	NULL
cytosolic	NULL
NF-KB	NULL
is	NULL
correlated	NULL
with	NULL
a	NULL
number	NULL
of	NULL
LPS-inducible	NULL
responses	NULL
.	NULL

We	NULL
sought	NULL
to	NULL
determine	NULL
if	NULL
this	NULL
pathway	NULL
were	NULL
present	NULL
in	NULL
CHO/CD14	NULL
cells	NULL
and	NULL
to	NULL
elucidate	NULL
the	NULL
relationship	NULL
of	NULL
NF-B	NULL
activation	NULL
to	NULL
the	NULL
CD14	NULL
receptor	NULL
system	NULL
.	NULL

LPS-stimulated	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
CHO/CD14	NULL
cells	NULL
resembled	NULL
the	NULL
same	NULL
response	NULL
in	NULL
the	NULL
murine	NULL
macrophage-like	NULL
cell	NULL
line	NULL
RAW	NULL
264.7	NULL
.	NULL

Protein	NULL
synthesis	NULL
inhibitors	NULL
and	NULL
corticosteroids	NULL
,	NULL
which	NULL
suppress	NULL
arachidonate	NULL
release	NULL
and	NULL
the	NULL
synthesis	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
CHO/CD14	NULL
or	NULL
RAW	NULL
264.7	NULL
cells	NULL
,	NULL
demonstrating	NULL
that	NULL
NF-KB	NULL
translocation	NULL
is	NULL
an	NULL
early	NULL
event	NULL
.	NULL

Although	NULL
TK	NULL
activity	NULL
was	NULL
consistently	NULL
observed	NULL
by	NULL
immunoblotting	NULL
extracts	NULL
from	NULL
activated	NULL
RAW	NULL
264.7	NULL
cells	NULL
,	NULL
LPS-induced	NULL
phosphotyrosine	NULL
residues	NULL
were	NULL
not	NULL
observed	NULL
from	NULL
similarly	NULL
treated	NULL
CHO/CD14	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
TK	NULL
inhibitors	NULL
herbimycin	NULL
A	NULL
and	NULL
genistein	NULL
failed	NULL
to	NULL
inhibit	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
CHO/CD14	NULL
or	NULL
RAW	NULL
264.7	NULL
cells	NULL
,	NULL
although	NULL
both	NULL
of	NULL
these	NULL
agents	NULL
inhibited	NULL
LPS-induced	NULL
TK	NULL
activity	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
imply	NULL
that	NULL
TK	NULL
activity	NULL
is	NULL
not	NULL
obligatory	NULL
for	NULL
CDI14-mediated	NULL
signal	NULL
transduction	NULL
to	NULL
occur	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
GM47127	NULL
and	NULL
AI83087	NULL
(	NULL
to	NULL
D.	NULL
T.	NULL
G.	NULL
)	NULL
,	NULL
AI18797	NULL
(	NULL
to	NULL
S.	NULL
N.	NULL
V.	NULL
)	NULL
,	NULL
and	NULL
AT29088	NULL
(	NULL
to	NULL
M.	NULL
J.	NULL
F.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

|	NULL
Evans	NULL
Foundation	NULL
postdoctoral	NULL
fellow	NULL
,	NULL
19	NULL
Recipient	NULL
of	NULL
an	NULL
American	NULL
Cancer	NULL
Society	NULL
Junior	NULL
Faculty	NULL
Award	NULL
.	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Maxwell	NULL
Finland	NULL
Laboratory	NULL
for	NULL
Infectious	NULL
Diseases	NULL
,	NULL
774	NULL
Albany	NULL
St.	NULL
,	NULL
Boston	NULL
MA	NULL
,	NULL
02118	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
617-534-7965	NULL
;	NULL
Fax	NULL
:	NULL
617-534-5280	NULL
.	NULL

Gram-negative	NULL
bacterial	NULL
sepsis	NULL
is	NULL
believed	NULL
to	NULL
be	NULL
initiated	NULL
by	NULL
interactions	NULL
between	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
,	NULL
'	NULL
endotoxin	NULL
)	NULL
,	NULL
a	NULL
bacterial	NULL
membrane	NULL
constituent	NULL
,	NULL
and	NULL
specific	NULL
receptors	NULL
on	NULL
mononuclear	NULL
phagocytes	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
release	NULL
of	NULL
cytokines	NULL
and	NULL
other	NULL
inflammatory	NULL
mediators	NULL
that	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
hemodynamic	NULL
instability	NULL
and	NULL
shock	NULL
that	NULL
are	NULL
characteristic	NULL
of	NULL
the	NULL
syndrome	NULL
.	NULL

CD14	NULL
,	NULL
the	NULL
only	NULL
molecule	NULL
that	NULL
has	NULL
been	NULL
shown	NULL
definitively	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
LPS-initiated	NULL
cellular	NULL
activation	NULL
,	NULL
is	NULL
a	NULL
53-kDa	NULL
glycosylphosphatidylinositol-linked	NULL
antigen	NULL
present	NULL
on	NULL
macrophages	NULL
and	NULL
neutrophils	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Serum	NULL
proteins	NULL
(	NULL
2-4	NULL
)	NULL
,	NULL
such	NULL
as	NULL
LPS-binding	NULL
protein	NULL
(	NULL
LBP	NULL
)	NULL
,	NULL
act	NULL
to	NULL
facilitate	NULL
binding	NULL
of	NULL
LPS	NULL
to	NULL
CD14	NULL
.	NULL

Both	NULL
53-	NULL
and	NULL
48-kDa	NULL
forms	NULL
of	NULL
CD14	NULL
are	NULL
present	NULL
as	NULL
soluble	NULL
LPS	NULL
receptors	NULL
in	NULL
human	NULL
serum	NULL
and	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
enable	NULL
LPS	NULL
responsiveness	NULL
in	NULL
certain	NULL
cell	NULL
types	NULL
in	NULL
vitro	NULL
(	NULL
5-12	NULL
)	NULL
.	NULL

A	NULL
central	NULL
question	NULL
in	NULL
endotoxin	NULL
research	NULL
is	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
CD14	NULL
induces	NULL
a	NULL
signal	NULL
following	NULL
ligand	NULL
binding	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
transmembrane	NULL
domain	NULL
.	NULL

Kitchens	NULL
et	NULL
al	NULL
.	NULL

(	NULL
11	NULL
)	NULL
demonstrated	NULL
that	NULL
LPS	NULL
receptor	NULL
antagonists	NULL
,	NULL
such	NULL
as	NULL
lipid	NULL
IVa	NULL
,	NULL
could	NULL
effectively	NULL
block	NULL
signaling	NULL
by	NULL
human	NULL
monocytes	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
when	NULL
used	NULL
at	NULL
nanomolar	NULL
concentrations	NULL
.	NULL

Yet	NULL
,	NULL
when	NULL
LPS	NULL
binding	NULL
to	NULL
the	NULL
cells	NULL
was	NULL
assessed	NULL
under	NULL
identical	NULL
conditions	NULL
,	NULL
micromolar	NULL
concentrations	NULL
of	NULL
antagonist	NULL
were	NULL
required	NULL
to	NULL
displace	NULL
LPS	NULL
from	NULL
CD14	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
a	NULL
significant	NULL
quantity	NULL
of	NULL
LPS	NULL
remained	NULL
associated	NULL
with	NULL
membrane-bound	NULL
CD14	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
inhibitory	NULL
concentrations	NULL
of	NULL
antagonist	NULL
,	NULL
suggested	NULL
that	NULL
these	NULL
agents	NULL
function	NULL
at	NULL
a	NULL
step	NULL
distal	NULL
to	NULL
LPS	NULL
binding	NULL
to	NULL
CD14	NULL
.	NULL

The	NULL
authors	NULL
hypothesized	NULL
that	NULL
a	NULL
membrane-associated	NULL
receptor	NULL
distinct	NULL
from	NULL
CD14	NULL
is	NULL
present	NULL
in	NULL
limiting	NULL
quantities	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
.	NULL

This	NULL
putative	NULL
receptor	NULL
might	NULL
function	NULL
as	NULL
a	NULL
signal	NULL
transducer	NULL
following	NULL
LPS	NULL
binding	NULL
to	NULL
CD14	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
role	NULL
of	NULL
CD14	NULL
may	NULL
be	NULL
to	NULL
act	NULL
as	NULL
a	NULL
transferase	NULL
,	NULL
delivering	NULL
LPS	NULL
to	NULL
a	NULL
downstream	NULL
molecule	NULL
which	NULL
then	NULL
effects	NULL
the	NULL
signal	NULL
across	NULL
the	NULL
plasma	NULL
membrane	NULL
.	NULL

Several	NULL
reports	NULL
have	NULL
described	NULL
endotoxin-induced	NULL
TK	NULL
activity	NULL
in	NULL
mononuclear	NULL
phagocytes	NULL
(	NULL
13-15	NULL
)	NULL
and	NULL
CD14-transfected	NULL
702/3	NULL
pre-B	NULL
cells	NULL
(	NULL
16	NULL
)	NULL
.	NULL

LPS	NULL
stimulation	NULL
resulted	NULL
in	NULL
prominent	NULL
phosphorylation	NULL
of	NULL
tyrosine	NULL
residues	NULL
in	NULL
various	NULL
proteins	NULL
with	NULL
molecular	NULL
masses	NULL
ranging	NULL
from	NULL
38	NULL
to	NULL
48	NULL
kDa	NULL
concomitant	NULL
with	NULL
dephosphorylation	NULL
of	NULL
several	NULL
protein	NULL
species	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
Stefanova	NULL
et	NULL
al	NULL
.	NULL

(	NULL
18	NULL
)	NULL
demonstrated	NULL
that	NULL
the	NULL
nonreceptor	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
p56	NULL
%	NULL
``	NULL
,	NULL
p58	NULL
``	NULL
*	NULL
,	NULL
and	NULL
p59	NULL
%	NULL
*	NULL
``	NULL
were	NULL
transiently	NULL
activated	NULL
in	NULL
human	NULL
monocytes	NULL
following	NULL
exposure	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
'The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
LPS	NULL
,	NULL
lipopolysaccharide	NULL
;	NULL
LBP	NULL
,	NULL
lipo-polysaccharide-binding	NULL
protein	NULL
;	NULL
TK	NULL
,	NULL
tyrosine	NULL
kinase	NULL
;	NULL
[	NULL
°HJ20:4	NULL
,	NULL
[	NULL
5,6,8,9,11,12,14,15-HJarachidonic	NULL
acid	NULL
;	NULL
CHO-K1	NULL
,	NULL
Chinese	NULL
hamster	NULL
ovary	NULL
fibroblast-K1	NULL
;	NULL
NF-kB	NULL
,	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
rsCD14	NULL
,	NULL
recombinant	NULL
soluble	NULL
CD14	NULL
;	NULL
PBS	NULL
,	NULL
phos-phate-buffered	NULL
saline	NULL
;	NULL
mAb	NULL
,	NULL
monoclonal	NULL
antibody	NULL
;	NULL
CNTF	NULL
,	NULL
ciliary	NULL
neurotrophic	NULL
factor	NULL
;	NULL
gp	NULL
,	NULL
glycoprotein	NULL
.	NULL

22253	NULL
22254	NULL
endotoxin	NULL
.	NULL

Pharmacologic	NULL
studies	NULL
with	NULL
TK	NULL
inhibitors	NULL
supported	NULL
the	NULL
concept	NULL
that	NULL
TK	NULL
activity	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
earliest	NULL
LPS-inducible	NULL
events	NULL
.	NULL

For	NULL
example	NULL
,	NULL
treatment	NULL
of	NULL
LPS-responsive	NULL
cells	NULL
with	NULL
the	NULL
TK	NULL
antagonist	NULL
herbimycin	NULL
A	NULL
blocked	NULL
induction	NULL
of	NULL
phosphotyrosine	NULL
residues	NULL
in	NULL
cellular	NULL
lysates	NULL
(	NULL
16	NULL
)	NULL
and	NULL
inhibited	NULL
induction	NULL
of	NULL
p564	NULL
``	NULL
,	NULL
p58	NULL
``	NULL
*	NULL
,	NULL
and	NULL
p59	NULL
%	NULL
*	NULL
``	NULL
activity	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Herbimycin	NULL
A	NULL
also	NULL
blocked	NULL
physiologic	NULL
responses	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
following	NULL
exposure	NULL
to	NULL
LPS	NULL
,	NULL
including	NULL
the	NULL
release	NULL
of	NULL
[	NULL
*HJarachidonic	NULL
acid	NULL
(	NULL
[	NULL
°H	NULL
]	NULL
20:4	NULL
(	NULL
13	NULL
)	NULL
)	NULL
and	NULL
the	NULL
production	NULL
of	NULL
cytokines	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
the	NULL
observations	NULL
outlined	NULL
above	NULL
suggested	NULL
that	NULL
TK	NULL
activity	NULL
is	NULL
essential	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
for	NULL
LPS-induced	NULL
signal	NULL
transduction	NULL
.	NULL

One	NULL
model	NULL
of	NULL
signaling	NULL
proposes	NULL
that	NULL
CD14	NULL
comprises	NULL
a	NULL
portion	NULL
of	NULL
an	NULL
LPS-specific	NULL
signaling	NULL
complex	NULL
which	NULL
includes	NULL
a	NULL
transmembrane	NULL
signal	NULL
transducer	NULL
with	NULL
TK	NULL
activity	NULL
.	NULL

Wild-type	NULL
hamster	NULL
CHO-K1	NULL
cells	NULL
are	NULL
not	NULL
responsive	NULL
to	NULL
LPS	NULL
.	NULL

The	NULL
construction	NULL
of	NULL
a	NULL
CHO	NULL
cell	NULL
line	NULL
,	NULL
CHO/CD14	NULL
,	NULL
which	NULL
expresses	NULL
membrane-bound	NULL
human	NULL
CD14	NULL
,	NULL
has	NULL
been	NULL
reported	NULL
previously	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
CHO/CD14	NULL
cells	NULL
with	NULL
as	NULL
little	NULL
as	NULL
1	NULL
ng	NULL
of	NULL
LPS/ml	NULL
resulted	NULL
in	NULL
the	NULL
release	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
J20:4	NULL
into	NULL
the	NULL
culture	NULL
supernatant	NULL
,	NULL
whereas	NULL
wild-type	NULL
CHO-K1	NULL
or	NULL
a	NULL
mock-transfected	NULL
CHO	NULL
cell	NULL
line	NULL
(	NULL
designated	NULL
CHO/NEO	NULL
)	NULL
failed	NULL
to	NULL
release	NULL
[	NULL
°H	NULL
]	NULL
20:4	NULL
at	NULL
concentrations	NULL
as	NULL
high	NULL
as	NULL
100	NULL
ug	NULL
of	NULL
LPS/ml	NULL
.	NULL

This	NULL
CD14-mediated	NULL
response	NULL
closely	NULL
resembled	NULL
[	NULL
°H	NULL
]	NULL
J20:4	NULL
release	NULL
from	NULL
the	NULL
murine	NULL
macrophage-like	NULL
cell	NULL
line	NULL
,	NULL
RAW	NULL
264.7	NULL
,	NULL
which	NULL
expresses	NULL
CD14	NULL
.	NULL

Another	NULL
macrophage	NULL
response	NULL
to	NULL
LPS-stimulation	NULL
is	NULL
the	NULL
translocation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
into	NULL
the	NULL
nucleus	NULL
(	NULL
19	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activation	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
sentinel	NULL
event	NULL
in	NULL
LPS-stimulated	NULL
macrophages	NULL
,	NULL
heralding	NULL
the	NULL
activation	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
(	NULL
20-22	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
production	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
,	NULL
type	NULL
1	NULL
virions	NULL
in	NULL
latently	NULL
infected	NULL
mononuclear	NULL
phagocytes	NULL
(	NULL
19	NULL
)	NULL
.	NULL

We	NULL
used	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
to	NULL
examine	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
CHO/CD14	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
,	NULL
to	NULL
determine	NULL
if	NULL
this	NULL
response	NULL
resembles	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
murine	NULL
macrophages	NULL
.	NULL

Expression	NULL
of	NULL
CD14	NULL
in	NULL
CHO-K1	NULL
cells	NULL
imparted	NULL
LPS-inducible	NULL
NF-kB	NULL
translocation	NULL
.	NULL

Both	NULL
wild-type	NULL
CHO-K1	NULL
or	NULL
CHO/NEO	NULL
cells	NULL
failed	NULL
to	NULL
respond	NULL
to	NULL
LPS	NULL
,	NULL
confirming	NULL
our	NULL
previous	NULL
observation	NULL
that	NULL
we	NULL
were	NULL
able	NULL
to	NULL
isolate	NULL
a	NULL
CD14-specific	NULL
pathway	NULL
of	NULL
LPS	NULL
activation	NULL
in	NULL
transfected	NULL
CHO	NULL
cells	NULL
.	NULL

Recombinant	NULL
soluble	NULL
CD14	NULL
(	NULL
rsCD14	NULL
)	NULL
,	NULL
when	NULL
added	NULL
simultaneously	NULL
with	NULL
LPS	NULL
to	NULL
wild-type	NULL
CHO	NULL
cells	NULL
,	NULL
failed	NULL
to	NULL
enable	NULL
responses	NULL
to	NULL
LPS	NULL
.	NULL

Surprisingly	NULL
,	NULL
LPS-inducible	NULL
TK	NULL
activity	NULL
was	NULL
not	NULL
apparent	NULL
in	NULL
CHO/CD14	NULL
cells	NULL
following	NULL
exposure	NULL
to	NULL
LPS	NULL
,	NULL
and	NULL
pharmacologic	NULL
inhibitors	NULL
of	NULL
TK	NULL
failed	NULL
to	NULL
prevent	NULL
LPS-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
either	NULL
CHO/CD14	NULL
or	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

When	NULL
taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
TK	NULL
activity	NULL
is	NULL
not	NULL
required	NULL
for	NULL
CD14-dependent	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents-Unless	NULL
otherwise	NULL
indicated	NULL
,	NULL
reagents	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
.	NULL

Ham	NULL
's	NULL
F-12	NULL
medium	NULL
with	NULL
L-glutamine	NULL
,	NULL
and	NULL
PBS	NULL
were	NULL
purchased	NULL
from	NULL
M.A	NULL
.	NULL

Bioproducts	NULL
(	NULL
Walkersville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Macrophage	NULL
serum-free	NULL
medium	NULL
was	NULL
purchased	NULL
from	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
Fetal	NULL
bovine	NULL
serum	NULL
(	NULL
LPS	NULL
<	NULL
0.02	NULL
ng/ml	NULL
)	NULL
was	NULL
from	NULL
HyClone	NULL
Laboratories	NULL
(	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
.	NULL

Pyro-gen-free	NULL
water	NULL
was	NULL
obtained	NULL
from	NULL
Baxter	NULL
Healthcare	NULL
Corp.	NULL
(	NULL
Deerfield	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Erbstatin	NULL
analog	NULL
,	NULL
herbimycin	NULL
A	NULL
,	NULL
and	NULL
genistein	NULL
were	NULL
obtained	NULL
from	NULL
Biomol	NULL
Research	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
(	NULL
Plymouth	NULL
Meeting	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

ReLPS	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
Nilofor	NULL
Qureshi	NULL
(	NULL
Middleton	NULL
Veterans	NULL
Administration	NULL
Hospital	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
and	NULL
was	NULL
extracted	NULL
with	NULL
phenol	NULL
from	NULL
Salmonella	NULL
minnesota	NULL
R595	NULL
.	NULL

LPS	NULL
solutions	NULL
were	NULL
stored	NULL
in	NULL
baked	NULL
glass	NULL
tubes	NULL
frozen	NULL
at	NULL
-20	NULL
°C	NULL
and	NULL
were	NULL
sonicated	NULL
in	NULL
an	NULL
80-watt	NULL
sonicator	NULL
bath	NULL
(	NULL
model	NULL
G112SP1G	NULL
;	NULL
Lab	NULL
Supply	NULL
Co.	NULL
,	NULL
Hicksville	NULL
,	NULL
NY	NULL
)	NULL
for	NULL
2	NULL
min	NULL
immediately	NULL
prior	NULL
to	NULL
use	NULL
.	NULL

rsCD14	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
Henri	NULL
Lichen-stein	NULL
(	NULL
Amgen	NULL
,	NULL
Inc.	NULL
,	NULL
Thousand	NULL
Oaks	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

MY4	NULL
(	NULL
anti-human	NULL
CD14	NULL
)	NULL
mAb	NULL
was	NULL
obtained	NULL
from	NULL
Coulter	NULL
(	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

Anti-phosphotyrosine	NULL
mAb	NULL
was	NULL
obtained	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Anti-human	NULL
p65	NULL
(	NULL
1226	NULL
)	NULL
mAb	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
Nancy	NULL
Rice	NULL
(	NULL
NCI	NULL
,	NULL
FCRF	NULL
,	NULL
LPS	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
xB	NULL
Is	NULL
Tyrosine	NULL
Kinase-independent	NULL
Frederick	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Poly	NULL
(	NULL
dI-dC	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Pharmacia	NULL
Biotech	NULL
.	NULL

Inc.	NULL
Prestained	NULL
protein	NULL
molecular	NULL
mass	NULL
markers	NULL
were	NULL
obtained	NULL
from	NULL
Bio-Rad	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Cell	NULL
Stimulation	NULL
Conditions-CHO-K1	NULL
(	NULL
ATCC	NULL
CCL61	NULL
)	NULL
and	NULL
RAW	NULL
264.7	NULL
(	NULL
ATCC	NULL
TIB71	NULL
)	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
.	NULL

CHO/CD14	NULL
and	NULL
CHO/NEO	NULL
cell	NULL
lines	NULL
were	NULL
transfected	NULL
with	NULL
plasmids	NULL
peDNA	NULL
UVCD14	NULL
and	NULL
pKONEO	NULL
,	NULL
or	NULL
pKO-NEO	NULL
alone	NULL
,	NULL
respectively	NULL
,	NULL
as	NULL
described	NULL
in	NULL
(	NULL
9	NULL
)	NULL
.	NULL

All	NULL
cell	NULL
lines	NULL
were	NULL
cultured	NULL
in	NULL
Ham	NULL
's	NULL
F-12	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
10	NULL
ug	NULL
of	NULL
ciprofloxacin/ml	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
atmosphere	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

The	NULL
day	NULL
before	NULL
each	NULL
experiment	NULL
,	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
plated/well	NULL
in	NULL
a	NULL
six-well	NULL
tissue	NULL
culture	NULL
dish	NULL
(	NULL
Costar	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
in	NULL
fresh	NULL
medium	NULL
.	NULL

At	NULL
the	NULL
time	NULL
of	NULL
stimulation	NULL
,	NULL
the	NULL
culture	NULL
medium	NULL
was	NULL
aspirated	NULL
and	NULL
replaced	NULL
with	NULL
800	NULL
ul	NULL
of	NULL
Ham	NULL
's	NULL
F-12	NULL
medium	NULL
containing	NULL
2	NULL
%	NULL
heat-inactivated	NULL
human	NULL
serum	NULL
,	NULL
10	NULL
pg	NULL
of	NULL
ciprofloxacin/ml	NULL
,	NULL
and	NULL
the	NULL
appropriate	NULL
stimulant	NULL
or	NULL
vehicle	NULL
.	NULL

Culture	NULL
dishes	NULL
were	NULL
then	NULL
returned	NULL
to	NULL
a	NULL
37°C	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
environment	NULL
for	NULL
0-240	NULL
min	NULL
and	NULL
then	NULL
placed	NULL
on	NULL
ice	NULL
just	NULL
prior	NULL
to	NULL
harvesting	NULL
.	NULL

Nuclear	NULL
Extracts-The	NULL
procedure	NULL
used	NULL
is	NULL
a	NULL
modification	NULL
of	NULL
previously	NULL
published	NULL
procedures	NULL
by	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
23	NULL
)	NULL
and	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
24	NULL
)	NULL
.	NULL

All	NULL
steps	NULL
were	NULL
performed	NULL
on	NULL
ice	NULL
or	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
mechanically	NULL
using	NULL
a	NULL
rubber	NULL
policeman	NULL
,	NULL
then	NULL
transferred	NULL
to	NULL
a	NULL
1.5-ml	NULL
tube	NULL
,	NULL
and	NULL
pelleted	NULL
in	NULL
a	NULL
microcentrifuge	NULL
(	NULL
Beckman	NULL
Microfuge	NULL
11	NULL
)	NULL
at	NULL
5,400	NULL
x	NULL
g	NULL
(	NULL
speed	NULL
6	NULL
)	NULL
for	NULL
10	NULL
s	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
PBS	NULL
containing	NULL
2	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
then	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
as	NULL
above	NULL
.	NULL

The	NULL
cell	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
400	NULL
pl	NULL
of	NULL
buffer	NULL
I	NULL
(	NULL
10	NULL
mu	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mu	NULL
KCl	NULL
,	NULL
0.3	NULL
my	NULL
EGTA	NULL
,	NULL
0.5	NULL
my	NULL
dithiothreitol	NULL
,	NULL
0.3	NULL
x	NULL
sucrose	NULL
,	NULL
1	NULL
mx	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
10	NULL
mm	NULL
B-glycerol	NULL
phosphate	NULL
,	NULL
and	NULL
1.0	NULL
ug/ml	NULL
each	NULL
of	NULL
the	NULL
following	NULL
protease	NULL
in-hibitors	NULL
:	NULL
aprotinin	NULL
,	NULL
antipain	NULL
,	NULL
leupeptin	NULL
,	NULL
chymostatin	NULL
,	NULL
and	NULL
pepstatin	NULL
A	NULL
)	NULL
.	NULL

The	NULL
tubes	NULL
were	NULL
placed	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
to	NULL
allow	NULL
the	NULL
cells	NULL
to	NULL
swell	NULL
and	NULL
facilitate	NULL
lysis	NULL
.	NULL

Nonidet	NULL
P-40	NULL
was	NULL
added	NULL
to	NULL
0.5	NULL
%	NULL
(	NULL
25	NULL
ul	NULL
of	NULL
a	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
stock	NULL
)	NULL
,	NULL
and	NULL
the	NULL
tubes	NULL
were	NULL
vortexed	NULL
at	NULL
full	NULL
speed	NULL
for	NULL
10	NULL
s.	NULL
Nuclei	NULL
were	NULL
harvested	NULL
by	NULL
centrifugation	NULL
at	NULL
7,200	NULL
x	NULL
g	NULL
(	NULL
speed	NULL
8	NULL
)	NULL
for	NULL
10	NULL
s	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
aspirated	NULL
,	NULL
and	NULL
the	NULL
nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
100	NULL
pul	NULL
of	NULL
buffer	NULL
II	NULL
(	NULL
20	NULL
my	NULL
Tris-	NULL
HC1	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
5	NULL
my	NULL
MgC1	NULL
,	NULL
,	NULL
$	NULL
20	NULL
my	NULL
KCl	NULL
,	NULL
0.2	NULL
mm	NULL
EGTA	NULL
,	NULL
0.5	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
of	NULL
protease	NULL
inhibitors	NULL
described	NULL
above	NULL
)	NULL
.	NULL

Nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
followed	NULL
by	NULL
centrifugation	NULL
at	NULL
13,500	NULL
x	NULL
g	NULL
(	NULL
full	NULL
speed	NULL
)	NULL
for	NULL
15	NULL
min	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
of	NULL
the	NULL
nuclear	NULL
extracts	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
concentration	NULL
reagent	NULL
per	NULL
the	NULL
manufacturer	NULL
's	NULL
in-structions	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
stored	NULL
at	NULL
~80	NULL
°C	NULL
until	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

EMSA-Two	NULL
synthetic	NULL
oligonucleotides	NULL
(	NULL
Oligos	NULL
Ete	NULL
.	NULL

,	NULL
Guilford	NULL
,	NULL
CT	NULL
)	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sequence	NULL
from	NULL
the	NULL
murine	NULL
immunoglobulin	NULL
«	NULL
light	NULL
chain	NULL
gene	NULL
enhancer	NULL
:	NULL
5	NULL
'	NULL
AGCTCAGAGGGGACTTTCCGAGAG	NULL
3	NULL
'	NULL
3	NULL
``	NULL
GTCTCCCCTGAAAGGCTCTCTCGA	NULL
5	NULL
'	NULL
Sequence	NULL
1	NULL
were	NULL
annealed	NULL
in	NULL
buffer	NULL
(	NULL
10	NULL
mx	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
50	NULL
mm	NULL
NaCl	NULL
,	NULL
10	NULL
my	NULL
MgCl	NULL
,	NULL
and	NULL
1	NULL
mm	NULL
dithiothreitol	NULL
)	NULL
.	NULL

Fifty	NULL
ng	NULL
of	NULL
this	NULL
material	NULL
was	NULL
end	NULL
labeled	NULL
using	NULL
Klenow	NULL
fragment	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
uCi	NULL
each	NULL
of	NULL
[	NULL
a-P	NULL
]	NULL
JdATP	NULL
and	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
,	NULL
DuPont	NULL
NEN	NULL
)	NULL
and	NULL
unlabeled	NULL
dGTP	NULL
and	NULL
dTTP	NULL
at	NULL
100	NULL
um	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
50	NULL
ul	NULL
as	NULL
described	NULL
in	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Unincorporated	NULL
nucleotides	NULL
were	NULL
removed	NULL
using	NULL
a	NULL
G-25	NULL
(	NULL
Pharmacia	NULL
)	NULL
spin	NULL
column	NULL
.	NULL

Two-tenths	NULL
ng	NULL
of	NULL
DNA	NULL
probe	NULL
(	NULL
20,000	NULL
cpm	NULL
)	NULL
was	NULL
used	NULL
in	NULL
a	NULL
DNA	NULL
binding	NULL
reaction	NULL
containing	NULL
4	NULL
pg	NULL
of	NULL
crude	NULL
nuclear	NULL
extract	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
reaction	NULL
also	NULL
contained	NULL
50	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
/ml	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
1	NULL
x	NULL
band	NULL
shift	NULL
buffer	NULL
(	NULL
10	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
40	NULL
mm	NULL
KCl	NULL
,	NULL
and	NULL
1	NULL
mm	NULL
dithiothreitol	NULL
)	NULL
.	NULL

Reactions	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
and	NULL
size	NULL
fractionated	NULL
by	NULL
electrophoresis	NULL
in	NULL
4	NULL
%	NULL
native	NULL
polyacrylamide	NULL
(	NULL
Protogel	NULL
brand	NULL
acrylamide	NULL
:	NULL
bisacrylamide	NULL
(	NULL
v/v	NULL
,	NULL
30:0.8	NULL
)	NULL
,	NULL
National	NULL
Diagnostics	NULL
,	NULL
At-lanta	NULL
,	NULL
GA	NULL
)	NULL
gels	NULL
containing	NULL
0.25	NULL
x	NULL
TBE	NULL
(	NULL
1	NULL
x	NULL
TBE	NULL
:	NULL
89	NULL
mn	NULL
Tris	NULL
borate	NULL
,	NULL
89	NULL
mm	NULL
boric	NULL
acid	NULL
,	NULL
and	NULL
2	NULL
mm	NULL
EDTA	NULL
)	NULL
which	NULL
had	NULL
been	NULL
preelectrophoresed	NULL
for	NULL
30	NULL
min	NULL
at	NULL
100	NULL
volts	NULL
.	NULL

Gels	NULL
were	NULL
run	NULL
at	NULL
10	NULL
volts/ecm	NULL
for	NULL
45	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Following	NULL
electrophoresis	NULL
,	NULL
gels	NULL
were	NULL
transferred	NULL
to	NULL
3MM	NULL
paper	NULL
(	NULL
Whatman	NULL
Ltd.	NULL
)	NULL
and	NULL
dried	NULL
in	NULL
a	NULL
gel	NULL
dryer	NULL
under	NULL
vacuum	NULL
at	NULL
80	NULL
°C	NULL
.	NULL

The	NULL
dried	NULL
gels	NULL
were	NULL
used	NULL
to	NULL
expose	NULL
XAR-2	NULL
x-ray	NULL
film	NULL
(	NULL
Eastman	NULL
Kodak	NULL
)	NULL
at	NULL
-80	NULL
°C	NULL
using	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

Competition	NULL
analysis	NULL
was	NULL
performed	NULL
by	NULL
including	NULL
a	NULL
25-molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
double-stranded	NULL
DNA	NULL
oligonucleotides	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reactions	NULL
last	NULL
and	NULL
then	NULL
processed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Unlabeled	NULL
NF-kB	NULL
probe	NULL
DNA	NULL
was	NULL
used	NULL
as	NULL
a	NULL
specific	NULL
competitor	NULL
.	NULL

Nonspecific	NULL
competitor	NULL
DNA	NULL
contained	NULL
the	NULL
NF-BA-binding	NULL
element	NULL
from	NULL
the	NULL
interleukin-18	NULL
gene	NULL
promoter	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
syn-	NULL
LPS	NULL
Activation	NULL
of	NULL
NF-kB	NULL
Is	NULL
Tyrosine	NULL
Kinase-independent	NULL
thetic	NULL
double-stranded	NULL
DNA	NULL
molecule	NULL
is	NULL
presented	NULL
below	NULL
:	NULL
5°	NULL
GATCTACTTCTGCTTTTG	NULL
3	NULL
``	NULL
3	NULL
'	NULL
ATGAAGACGAAAACCTAG	NULL
5	NULL
!	NULL

Sequznor	NULL
2	NULL
Anti-phosphotyrosine	NULL
Immunoblotting-Following	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
(	NULL
1-2	NULL
x	NULL
10°	NULL
)	NULL
,	NULL
culture	NULL
medium	NULL
was	NULL
aspirated	NULL
,	NULL
and	NULL
60	NULL
ul	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
100	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
(	NULL
22°C	NULL
)	NULL
,	NULL
137	NULL
mm	NULL
NaCl	NULL
,	NULL
2	NULL
mm	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
glycerol	NULL
(	NULL
v/v	NULL
)	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
1	NULL
m	NULL
sodium	NULL
vanadate	NULL
,	NULL
50	NULL
mm	NULL
sodium	NULL
fluoride	NULL
,	NULL
100	NULL
um	NULL
quercitin	NULL
,	NULL
100	NULL
um	NULL
1-tosylamido-2-phenylethyl	NULL
chloro-methyl	NULL
ketone	NULL
,	NULL
0.5	NULL
mm	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
20	NULL
um	NULL
leupeptin	NULL
,	NULL
0.14	NULL
unit/ml	NULL
aprotinin	NULL
)	NULL
was	NULL
added	NULL
to	NULL
each	NULL
well	NULL
.	NULL

The	NULL
plates	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
collected	NULL
and	NULL
cleared	NULL
by	NULL
centrifugation	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
15	NULL
min	NULL
in	NULL
a	NULL
microcentrifuge	NULL
(	NULL
13,500	NULL
x	NULL
g	NULL
)	NULL
,	NULL
and	NULL
protein	NULL
concentrations	NULL
were	NULL
determined	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
protein	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
4	NULL
x	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
(	NULL
62	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
6.8	NULL
,	NULL
2	NULL
%	NULL
glycerol	NULL
,	NULL
5	NULL
%	NULL
SDS	NULL
,	NULL
0.05	NULL
%	NULL
B-mercaptoethanol	NULL
,	NULL
and	NULL
0.05	NULL
%	NULL
brom-phenol	NULL
blue	NULL
)	NULL
,	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
,	NULL
and	NULL
frozen	NULL
at	NULL
-80	NULL
°C	NULL
until	NULL
analysis	NULL
by	NULL
immunoblotting	NULL
.	NULL

Samples	NULL
were	NULL
electrophoresed	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
.	NULL

Following	NULL
electrophoresis	NULL
,	NULL
proteins	NULL
were	NULL
blotted	NULL
onto	NULL
Im-mobilon-P	NULL
membranes	NULL
(	NULL
Millipore	NULL
Corp.	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
and	NULL
then	NULL
probed	NULL
with	NULL
anti-phosphotyrosine	NULL
mAb	NULL
using	NULL
a	NULL
horseradish	NULL
peroxidase-based	NULL
chemiluminescence	NULL
system	NULL
as	NULL
described	NULL
in	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Kinase	NULL
Assay-For	NULL
immunoprecipitation	NULL
assays	NULL
,	NULL
CHO/CD14	NULL
and	NULL
CHO/NEO	NULL
cells	NULL
were	NULL
grown	NULL
on	NULL
100-mm	NULL
tissue	NULL
culture	NULL
dishes	NULL
to	NULL
approximately	NULL
80	NULL
%	NULL
confluence	NULL
(	NULL
10	NULL
'	NULL
cells	NULL
)	NULL
in	NULL
Ham	NULL
's	NULL
F-12	NULL
medium	NULL
containing	NULL
L-glutamine	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
penicillin	NULL
G	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
,	NULL
and	NULL
streptomycin	NULL
(	NULL
100	NULL
mg/ml	NULL
)	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
containing	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
.	NULL

The	NULL
growth	NULL
medium	NULL
was	NULL
aspirated	NULL
and	NULL
replaced	NULL
with	NULL
5	NULL
ml	NULL
of	NULL
fresh	NULL
medium	NULL
containing	NULL
1	NULL
ug/ml	NULL
LPS	NULL
when	NULL
required	NULL
.	NULL

After	NULL
the	NULL
stimulation	NULL
period	NULL
,	NULL
the	NULL
medium	NULL
was	NULL
aspirated	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
5	NULL
ml	NULL
of	NULL
ice-cold	NULL
PBS	NULL
containing	NULL
1	NULL
mm	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
and	NULL
1	NULL
ma	NULL
sodium	NULL
vanadate	NULL
(	NULL
PBSPV	NULL
)	NULL
,	NULL
and	NULL
lysed	NULL
in	NULL
ice-cold	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mai	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.2	NULL
,	NULL
140	NULL
mm	NULL
NaCl	NULL
,	NULL
2	NULL
mm	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
1	NULL
mi	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
15	NULL
milliunits/ml	NULL
aprotinin	NULL
,	NULL
20	NULL
mam	NULL
leupeptin	NULL
,	NULL
1	NULL
mm	NULL
sodium	NULL
vanadate	NULL
,	NULL
and	NULL
0.1	NULL
mm	NULL
1-chloro-3-tosylamido-7-amino-2-heptanone	NULL
)	NULL
.	NULL

THP-1	NULL
cells	NULL
(	NULL
ATCC	NULL
TIB	NULL
202	NULL
)	NULL
were	NULL
seeded	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
x	NULL
10°	NULL
cells/100-mm	NULL
dish	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
growth	NULL
medium	NULL
(	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
penicillin	NULL
G	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
,	NULL
streptomycin	NULL
(	NULL
100	NULL
mg/ml	NULL
)	NULL
,	NULL
and	NULL
0.1	NULL
um	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
,	NULL
(	NULL
Biomol	NULL
Research	NULL
Laboratories	NULL
,	NULL
Plymouth	NULL
Meeting	NULL
,	NULL
PA	NULL
)	NULL
)	NULL
.	NULL

After	NULL
72	NULL
h	NULL
,	NULL
fresh	NULL
growth	NULL
medium	NULL
(	NULL
5	NULL
ml	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
another	NULL
24	NULL
h.	NULL
For	NULL
LPS	NULL
stimulation	NULL
,	NULL
an	NULL
additional	NULL
5	NULL
ml	NULL
of	NULL
growth	NULL
medium	NULL
containing	NULL
LPS	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1	NULL
ug/ml	NULL
was	NULL
added	NULL
.	NULL

Next	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
gently	NULL
removed	NULL
from	NULL
the	NULL
plates	NULL
using	NULL
a	NULL
cell	NULL
scraper	NULL
,	NULL
washed	NULL
with	NULL
PBSPV	NULL
,	NULL
and	NULL
lysed	NULL
in	NULL
lysis	NULL
buffer	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
solid	NULL
phase	NULL
immunoprecipitation	NULL
and	NULL
kinase	NULL
assays	NULL
as	NULL
described	NULL
(	NULL
18	NULL
,	NULL
26	NULL
)	NULL
with	NULL
minor	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
96-well	NULL
U-bottom	NULL
Microtest	NULL
III	NULL
plates	NULL
(	NULL
Falcon	NULL
Labware	NULL
,	NULL
Oxnard	NULL
,	NULL
CA	NULL
)	NULL
were	NULL
coated	NULL
with	NULL
100	NULL
ul	NULL
of	NULL
goat	NULL
anti-mouse	NULL
or	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
(	NULL
Sigma	NULL
)	NULL
(	NULL
0.1	NULL
mg/ml	NULL
)	NULL
at	NULL
37°C	NULL
for	NULL
2	NULL
h.	NULL
The	NULL
plates	NULL
were	NULL
then	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
200	NULL
ul	NULL
of	NULL
PBS	NULL
.	NULL

Next	NULL
,	NULL
100	NULL
ul	NULL
of	NULL
mouse	NULL
mAb	NULL
against	NULL
CD14	NULL
,	NULL
MY4	NULL
(	NULL
20	NULL
ug/ml	NULL
)	NULL
,	NULL
or	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
against	NULL
lyn	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
;	NULL
10	NULL
ug/ml	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
wells	NULL
and	NULL
incubated	NULL
overnight	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
wells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
blocked	NULL
with	NULL
0.2	NULL
%	NULL
gelatin	NULL
,	NULL
1	NULL
%	NULL
gly-cine	NULL
in	NULL
PBS	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

The	NULL
blocking	NULL
solution	NULL
was	NULL
removed	NULL
,	NULL
and	NULL
100-ul	NULL
aliquots	NULL
of	NULL
the	NULL
lysates	NULL
(	NULL
1	NULL
mg/ml	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
wells	NULL
.	NULL

After	NULL
a	NULL
4-h	NULL
incubation	NULL
at	NULL
4°C	NULL
,	NULL
the	NULL
lysates	NULL
were	NULL
aspirated	NULL
,	NULL
the	NULL
wells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
lysis	NULL
buffer	NULL
,	NULL
and	NULL
50	NULL
ul	NULL
of	NULL
kinase	NULL
assay	NULL
buffer	NULL
(	NULL
25	NULL
mm	NULL
Hepes	NULL
,	NULL
pH	NULL
7.2	NULL
,	NULL
3	NULL
mm	NULL
MnCl	NULL
,	NULL
,	NULL
20	NULL
my	NULL
MgCl	NULL
,	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
and	NULL
5	NULL
uCi	NULL
of	NULL
[	NULL
y-*P	NULL
]	NULL
JATP	NULL
(	NULL
3,000	NULL
Ci/mm	NULL
;	NULL
Amersham	NULL
Corp.	NULL
)	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
wells	NULL
.	NULL

After	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
the	NULL
proteins	NULL
were	NULL
eluted	NULL
with	NULL
SDS	NULL
sample	NULL
buffer	NULL
and	NULL
subjected	NULL
to	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
autoradiography	NULL
.	NULL

RESULTS	NULL
LPS	NULL
Induces	NULL
NF-	NULL
«	NULL
B	NULL
Translocation	NULL
in	NULL
CHO/CD14	NULL
Cells-Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
wild-type	NULL
CHO-K1	NULL
cells	NULL
do	NULL
not	NULL
release	NULL
[	NULL
°H	NULL
]	NULL
20:4	NULL
in	NULL
response	NULL
to	NULL
treatment	NULL
with	NULL
LPS	NULL
(	NULL
9	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
reported	NULL
previously	NULL
the	NULL
construction	NULL
of	NULL
a	NULL
CHO	NULL
cell	NULL
line	NULL
,	NULL
CHO/CD14	NULL
,	NULL
which	NULL
expresses	NULL
moderate	NULL
levels	NULL
of	NULL
surface	NULL
human	NULL
CD14	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
CHO/CD14	NULL
cells	NULL
with	NULL
as	NULL
little	NULL
as	NULL
1	NULL
ng	NULL
of	NULL
LPS/ml	NULL
resulted	NULL
in	NULL
the	NULL
release	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
20:4	NULL
into	NULL
the	NULL
culture	NULL
supernatant	NULL
.	NULL

This	NULL
CD14-mediated	NULL
response	NULL
closely	NULL
re	NULL
22255	NULL
15	NULL
30	NULL
60	NULL
120	NULL
240	NULL
«	NULL
g	NULL
-.-	NULL
.	NULL

@	NULL
@	NULL
@	NULL
=	NULL
a	NULL
NE	NULL
0	NULL
5	NULL
10	NULL
b	NULL
0	NULL
0.5	NULL
1	NULL
3	NULL
S5	NULL
c	NULL
NS	NULL
SP	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
in	NULL
CD14-transfected	NULL
CHO	NULL
cells	NULL
.	NULL

CHO/CD14	NULL
(	NULL
panel	NULL
a	NULL
)	NULL
and	NULL
CHO/NEO	NULL
(	NULL
panel	NULL
b	NULL
)	NULL
monolayers	NULL
containing	NULL
2-3	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
stimulated	NULL
,	NULL
in	NULL
0.8	NULL
ml	NULL
of	NULL
Ham	NULL
's	NULL
F-12	NULL
containing	NULL
2	NULL
%	NULL
heat-inactivated	NULL
human	NULL
serum	NULL
,	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
LPS/ml	NULL
for	NULL
the	NULL
times	NULL
(	NULL
in	NULL
min	NULL
)	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
combined	NULL
with	NULL
autoradiography	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
using	NULL
*°P-labeled	NULL
probe	NULL
DNA	NULL
containing	NULL
the	NULL
immunoglobulin	NULL
x	NULL
gene	NULL
enhancer	NULL
consensus	NULL
sequence	NULL
.	NULL

Panel	NULL
c	NULL
,	NULL
competition	NULL
analysis	NULL
was	NULL
performed	NULL
by	NULL
including	NULL
a	NULL
25-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
specific	NULL
(	NULL
SP	NULL
)	NULL
or	NULL
nonspecific	NULL
(	NULL
NS	NULL
)	NULL
oligonucleotide	NULL
in	NULL
the	NULL
DNA	NULL
binding	NULL
reactions	NULL
assembled	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
CHO/CD14	NULL
cells	NULL
treated	NULL
with	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
for	NULL
1	NULL
h.	NULL
sembled	NULL
[	NULL
*H	NULL
]	NULL
20:4	NULL
release	NULL
from	NULL
the	NULL
murine	NULL
macrophage-like	NULL
cell	NULL
line	NULL
,	NULL
RAW	NULL
264.7	NULL
,	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
stimulation	NULL
.	NULL

An	NULL
additional	NULL
macrophage	NULL
response	NULL
to	NULL
LPS	NULL
is	NULL
the	NULL
translocation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
,	NULL
NF-kB	NULL
(	NULL
19	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
chose	NULL
the	NULL
EMSA	NULL
to	NULL
study	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
CHO/CD14	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
to	NULL
determine	NULL
whether	NULL
this	NULL
response	NULL
is	NULL
similar	NULL
to	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
macrophages	NULL
.	NULL

CHO/CD14	NULL
and	NULL
CHO/NEO	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
for	NULL
increasing	NULL
periods	NULL
of	NULL
time	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
and	NULL
were	NULL
subjected	NULL
to	NULL
EMSA	NULL
using	NULL
a	NULL
DNA	NULL
probe	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B-binding	NULL
element	NULL
from	NULL
the	NULL
murine	NULL
immunoglobulin	NULL
k	NULL
light	NULL
chain	NULL
gene	NULL
enhancer	NULL
.	NULL

Nuclear	NULL
localization	NULL
of	NULL
NF-kB	NULL
was	NULL
evident	NULL
in	NULL
CHO/CD14	NULL
cells	NULL
within	NULL
15	NULL
min	NULL
and	NULL
maximal	NULL
within	NULL
30	NULL
min	NULL
following	NULL
exposure	NULL
to	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

1a	NULL
)	NULL
.	NULL

Peak	NULL
activation	NULL
of	NULL
the	NULL
CHO/CD14	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
10-fold	NULL
increase	NULL
in	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
levels	NULL
as	NULL
determined	NULL
by	NULL
scanning	NULL
densitometry	NULL
.	NULL

Nuclear	NULL
levels	NULL
of	NULL
NF-kB	NULL
returned	NULL
to	NULL
basal	NULL
levels	NULL
within	NULL
2	NULL
h	NULL
following	NULL
exposure	NULL
to	NULL
LPS	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
treatment	NULL
of	NULL
CHO/NEO	NULL
cells	NULL
with	NULL
LPS	NULL
did	NULL
not	NULL
result	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

16	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
CHO	NULL
cells	NULL
can	NULL
acquire	NULL
responsiveness	NULL
to	NULL
LPS	NULL
as	NULL
a	NULL
result	NULL
of	NULL
CD14	NULL
expression	NULL
.	NULL

These	NULL
data	NULL
extend	NULL
our	NULL
earlier	NULL
findings	NULL
that	NULL
CHO/	NULL
CD14	NULL
cells	NULL
release	NULL
arachidonic	NULL
acid	NULL
metabolites	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
,	NULL
by	NULL
demonstrating	NULL
that	NULL
NF-kB	NULL
translocation	NULL
is	NULL
also	NULL
induced	NULL
by	NULL
LPS	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Competition	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
CHO/CD14	NULL
cells	NULL
stimulated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
LPS/ml	NULL
to	NULL
demonstrate	NULL
specificity	NULL
of	NULL
the	NULL
retarded	NULL
complexes	NULL
observed	NULL
in	NULL
the	NULL
EMSA	NULL
.	NULL

Inclusion	NULL
of	NULL
a	NULL
25-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
double-stranded	NULL
NF-kB	NULL
oligonucleotide	NULL
in	NULL
the	NULL
DNA	NULL
binding	NULL
reaction	NULL
containing	NULL
nuclear	NULL
extracts	NULL
from	NULL
stimulated	NULL
CHO/CD14	NULL
cells	NULL
effectively	NULL
blocked	NULL
LPS-induced	NULL
formation	NULL
of	NULL
DNA/protein	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

1¢	NULL
)	NULL
.	NULL

Inclusion	NULL
of	NULL
a	NULL
25-fold	NULL
molar	NULL
22256	NULL
CHO/CDI4	NULL
NE	NULL
0	NULL
0.1	NULL
1.0	NULL
10	NULL
100	NULL
bb	NULL
tut	NULL
#	NULL
#	NULL
RAW	NULL
NE	NULL
0	NULL
0.1	NULL
1.0	NULL
10	NULL
100	NULL
[	NULL
LPS	NULL
]	NULL
(	NULL
ng/m	NULL
)	NULL
b+	NULL
C	NULL
tus	NULL
thd	NULL
mmm	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

LPS	NULL
dose	NULL
response	NULL
in	NULL
CHO/CD14	NULL
cells	NULL
.	NULL

Monolayers	NULL
of	NULL
CHO/CD14	NULL
and	NULL
RAW	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10¢/well	NULL
of	NULL
a	NULL
six-well	NULL
dish	NULL
)	NULL
were	NULL
treated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
LPS	NULL
(	NULL
0-100	NULL
ng/ml	NULL
)	NULL
suspended	NULL
in	NULL
Ham	NULL
's	NULL
F-12	NULL
medium	NULL
containing	NULL
2	NULL
%	NULL
human	NULL
serum	NULL
.	NULL

The	NULL
stimulation	NULL
was	NULL
stopped	NULL
by	NULL
placing	NULL
the	NULL
tissue	NULL
culture	NULL
dishes	NULL
on	NULL
ice	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
subjected	NULL
to	NULL
EMSA	NULL
and	NULL
autoradiography	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

excess	NULL
of	NULL
a	NULL
nonspecific	NULL
double-stranded	NULL
DNA	NULL
probe	NULL
in	NULL
the	NULL
DNA	NULL
binding	NULL
reaction	NULL
did	NULL
not	NULL
result	NULL
in	NULL
competition	NULL
for	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
radiolabeled	NULL
DNA	NULL
probe	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
observed	NULL
DNA-protein	NULL
complex	NULL
arises	NULL
through	NULL
sequence-specific	NULL
interactions	NULL
with	NULL
the	NULL
NF-kB	NULL
consensus	NULL
sequence	NULL
.	NULL

Furthermore	NULL
,	NULL
inclusion	NULL
of	NULL
anti-human	NULL
mAbs	NULL
,	NULL
specific	NULL
for	NULL
NF-	NULL
«	NULL
B-related	NULL
proteins	NULL
in	NULL
the	NULL
DNA	NULL
binding	NULL
reactions	NULL
,	NULL
demonstrated	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
a	NULL
component	NULL
of	NULL
the	NULL
DNA-protein	NULL
complex	NULL
observed	NULL
in	NULL
CHO/CD14	NULL
cells	NULL
following	NULL
stimulation	NULL
with	NULL
endotoxin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

LPS	NULL
Induces	NULL
NF-kB	NULL
Translocation	NULL
in	NULL
CHO/CD14	NULL
Cells	NULL
in	NULL
a	NULL
Manner	NULL
Similar	NULL
to	NULL
the	NULL
Murine	NULL
Macrophage-like	NULL
Cell	NULL
Line	NULL
,	NULL
RAW	NULL
264.7-LPS	NULL
dose-response	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
compare	NULL
NF-kB	NULL
translocation	NULL
in	NULL
CHO/CD14	NULL
cells	NULL
versus	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
LPS	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
subjected	NULL
to	NULL
EMSA	NULL
.	NULL

As	NULL
little	NULL
as	NULL
0.1	NULL
ng	NULL
of	NULL
LPS/ml	NULL
was	NULL
sufficient	NULL
to	NULL
activate	NULL
NF-kB	NULL
translocation	NULL
in	NULL
CHO/CD14	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
with	NULL
LPS	NULL
dose-response	NULL
experiments	NULL
performed	NULL
on	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Response	NULL
was	NULL
maximal	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
between	NULL
10	NULL
and	NULL
100	NULL
ng	NULL
of	NULL
LPS/	NULL
ml	NULL
.	NULL

These	NULL
results	NULL
were	NULL
consistent	NULL
with	NULL
CD14-mediated	NULL
signaling	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
through	NULL
similar	NULL
signal	NULL
transduction	NULL
pathways	NULL
resulting	NULL
in	NULL
NF-kB	NULL
activation	NULL
.	NULL

mAbs	NULL
to	NULL
CD14	NULL
Inhibit	NULL
NF-	NULL
«	NULL
B	NULL
Activation	NULL
in	NULL
CHO/CD14	NULL
Cells-Many	NULL
macrophage	NULL
responses	NULL
to	NULL
LPS	NULL
,	NULL
including	NULL
[	NULL
*H	NULL
]	NULL
20:4	NULL
release	NULL
,	NULL
increased	NULL
TK	NULL
activity	NULL
,	NULL
and	NULL
cytokine	NULL
release	NULL
,	NULL
can	NULL
be	NULL
inhibited	NULL
by	NULL
treating	NULL
cells	NULL
with	NULL
the	NULL
anti-CD14	NULL
mAb	NULL
MY4	NULL
(	NULL
27	NULL
)	NULL
.	NULL

CHO/CD14	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
LPS	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
200	NULL
ug	NULL
of	NULL
MY4	NULL
mAb/ml	NULL
.	NULL

After	NULL
incubation	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
1	NULL
h	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

Treatment	NULL
of	NULL
CHO/CD14	NULL
cells	NULL
with	NULL
10	NULL
ng	NULL
of	NULL
LPS/ml	NULL
resulted	NULL
in	NULL
NF-kB	NULL
activation	NULL
.	NULL

This	NULL
response	NULL
was	NULL
blocked	NULL
by	NULL
adding	NULL
MY4	NULL
mAb	NULL
and	NULL
LPS	NULL
simultaneously	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Control	NULL
experiments	NULL
using	NULL
control	NULL
IgG	NULL
,	NULL
,	NULL
antibodies	NULL
did	NULL
not	NULL
result	NULL
in	NULL
loss	NULL
of	NULL
NF-kB	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
CHO/CD14	NULL
cells	NULL
is	NULL
initiated	NULL
through	NULL
LPS	NULL
binding	NULL
to	NULL
transfected	NULL
human	NULL
CD14	NULL
.	NULL

Soluble	NULL
CD14	NULL
Fails	NULL
to	NULL
Enable	NULL
Responses	NULL
to	NULL
LPS	NULL
in	NULL
CHO-K1	NULL
Cells-Several	NULL
recent	NULL
reports	NULL
have	NULL
demonstrated	NULL
that	NULL
soluble	NULL
CD14	NULL
can	NULL
confer	NULL
LPS	NULL
sensitivity	NULL
to	NULL
endothelial	NULL
cells	NULL
and	NULL
other	NULL
cell	NULL
lines	NULL
that	NULL
do	NULL
not	NULL
express	NULL
detectable	NULL
levels	NULL
of	NULL
CD14	NULL
(	NULL
8	NULL
,	NULL
28-32	NULL
)	NULL
,	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
LBP	NULL
.	NULL

We	NULL
have	NULL
reported	NULL
previously	NULL
that	NULL
serum	NULL
,	NULL
which	NULL
contains	NULL
both	NULL
LBP	NULL
and	NULL
soluble	NULL
CD14	NULL
,	NULL
failed	NULL
to	NULL
enable	NULL
LPS-induced	NULL
[	NULL
°H	NULL
]	NULL
20:4	NULL
release	NULL
in	NULL
CHO	NULL
cells	NULL
that	NULL
have	NULL
not	NULL
been	NULL
transfected	NULL
with	NULL
CD14	NULL
(	NULL
9	NULL
)	NULL
.	NULL

As	NULL
demonstrated	NULL
above	NULL
,	NULL
serum	NULL
also	NULL
failed	NULL
to	NULL
substitute	NULL
for	NULL
membrane-bound	NULL
LPS	NULL
Activation	NULL
of	NULL
NF-kB	NULL
Is	NULL
Tyrosine	NULL
Kinase-independent	NULL
[	NULL
my4	NULL
-	NULL
_+	NULL
_-	NULL
_+	NULL
]	NULL
[	NULL
-	NULL
__+	NULL
scpi4	NULL
]	NULL
[	NULL
ups	NULL
0	NULL
0	NULL
10	NULL
10	NULL
_	NULL
10	NULL
10	NULL
|	NULL
|	NULL
N	NULL
»	NULL
uP	NULL
TP	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Effects	NULL
of	NULL
anti-CD14	NULL
mAb	NULL
in	NULL
CHO/CD14	NULL
cells	NULL
and	NULL
effect	NULL
of	NULL
rsCD14	NULL
in	NULL
CHO-K1	NULL
cells	NULL
.	NULL

CHO/CD14	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
10	NULL
ng	NULL
of	NULL
LPS/ml	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
200	NULL
ug	NULL
MY4	NULL
(	NULL
anti-CD14	NULL
monoclonal	NULL
antibody	NULL
)	NULL
/ml	NULL
in	NULL
Ham	NULL
's	NULL
F-12	NULL
medium	NULL
containing	NULL
2	NULL
%	NULL
heat-inactivated	NULL
human	NULL
serum	NULL
;	NULL
the	NULL
LPS	NULL
and	NULL
the	NULL
monoclonal	NULL
antibody	NULL
were	NULL
premixed	NULL
and	NULL
added	NULL
simultaneously	NULL
.	NULL

As	NULL
part	NULL
of	NULL
the	NULL
same	NULL
experiment	NULL
,	NULL
monolayers	NULL
of	NULL
wild-type	NULL
CHO-K1	NULL
cells	NULL
were	NULL
washed	NULL
free	NULL
of	NULL
serum	NULL
three	NULL
times	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
Ham	NULL
's	NULL
F-12	NULL
and	NULL
were	NULL
stimulated	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
LPS/ml	NULL
for	NULL
1	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
rsCD14	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
in	NULL
macrophage	NULL
serum-free	NULL
medium	NULL
(	NULL
which	NULL
contains	NULL
0.5	NULL
%	NULL
albumin	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
and	NULL
autoradiography	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

CD14	NULL
when	NULL
LPS-induced	NULL
translocation	NULL
of	NULL
NF-kB	NULL
was	NULL
exam-ined	NULL
.	NULL

We	NULL
examined	NULL
this	NULL
issue	NULL
in	NULL
greater	NULL
depth	NULL
using	NULL
rsCD14	NULL
.	NULL

The	NULL
bioactivity	NULL
of	NULL
rsCD14	NULL
was	NULL
confirmed	NULL
by	NULL
its	NULL
ability	NULL
to	NULL
enable	NULL
LPS	NULL
induction	NULL
of	NULL
tissue	NULL
factor	NULL
production	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL
``	NULL

Wild-type	NULL
CHO-K1	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
ng	NULL
of	NULL
LPS/ml	NULL
,	NULL
under	NULL
serum-free	NULL
conditions	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
10	NULL
ug	NULL
of	NULL
rsCD14/ml	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
after	NULL
1	NULL
h	NULL
of	NULL
stimulation	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

CHO-K1	NULL
cells	NULL
were	NULL
not	NULL
responsive	NULL
to	NULL
LPS	NULL
in	NULL
either	NULL
the	NULL
absence	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
rsCD14	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
under	NULL
serum-free	NULL
conditions	NULL
,	NULL
membrane-bound	NULL
CD14	NULL
is	NULL
required	NULL
for	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
CHO	NULL
cells	NULL
.	NULL

NF-kB	NULL
Activation	NULL
in	NULL
CHO/CD14	NULL
and	NULL
RAW	NULL
264.7	NULL
cells	NULL
Is	NULL
an	NULL
Early	NULL
Event	NULL
in	NULL
LPS	NULL
Signal	NULL
Transduction	NULL
and	NULL
Does	NULL
Not	NULL
Require	NULL
Concomitant	NULL
mRNA	NULL
or	NULL
Protein	NULL
Synthesis-CHO/CD14	NULL
and	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
either	NULL
1.0	NULL
um	NULL
actinomycin	NULL
D	NULL
or	NULL
cycloheximide	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
stimulation	NULL
with	NULL
LPS	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
these	NULL
conditions	NULL
inhibited	NULL
the	NULL
release	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
20:4	NULL
metabolites	NULL
following	NULL
stimulation	NULL
of	NULL
CHO/CD14	NULL
cells	NULL
with	NULL
endotoxin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

EMSA	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
these	NULL
cells	NULL
demonstrated	NULL
that	NULL
,	NULL
unlike	NULL
arachidonate	NULL
release	NULL
,	NULL
CD14-dependent	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
did	NULL
not	NULL
require	NULL
ongoing	NULL
transcription	NULL
or	NULL
translation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
macrophages	NULL
with	NULL
anti-inflammatory	NULL
glucocor-ticoid	NULL
hormones	NULL
can	NULL
effectively	NULL
block	NULL
many	NULL
of	NULL
their	NULL
responses	NULL
to	NULL
LPS	NULL
including	NULL
the	NULL
release	NULL
of	NULL
cytokines	NULL
.	NULL

CHO/CD14	NULL
and	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
dexamethasone	NULL
for	NULL
30	NULL
min	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
LPS	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10	NULL
ng/ml	NULL
.	NULL

Nuclear	NULL
localization	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
stimulation	NULL
was	NULL
quantitated	NULL
by	NULL
EMSA	NULL
of	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
was	NULL
not	NULL
effected	NULL
by	NULL
pretreatment	NULL
of	NULL
cells	NULL
with	NULL
dexamethasone	NULL
.	NULL

TK	NULL
Activity	NULL
Is	NULL
Not	NULL
Apparent	NULL
in	NULL
CHO	NULL
Cells	NULL
Stimulated	NULL
with	NULL
LPS-Recently	NULL
,	NULL
several	NULL
reports	NULL
have	NULL
presented	NULL
data	NULL
suggesting	NULL
that	NULL
TK	NULL
activity	NULL
is	NULL
involved	NULL
in	NULL
CD14-dependent	NULL
LPS-induced	NULL
signaling	NULL
in	NULL
LPS-responsive	NULL
monocytes	NULL
or	NULL
macrophages	NULL
(	NULL
13-15	NULL
,	NULL
18	NULL
)	NULL
and	NULL
a	NULL
CD14-transfected	NULL
70	NULL
%	NULL
/3	NULL
pre-B	NULL
lymphocytic	NULL
cell	NULL
line	NULL
(	NULL
16	NULL
)	NULL
.	NULL

We	NULL
sought	NULL
to	NULL
determine	NULL
if	NULL
endotoxin	NULL
activated	NULL
a	NULL
CD14-associated	NULL
TK	NULL
in	NULL
CHO/CD14	NULL
cells	NULL
.	NULL

CHO/	NULL
CD14	NULL
,	NULL
CHO/NEO	NULL
,	NULL
and	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
2	NULL
D.	NULL
T.	NULL
Golenbock	NULL
,	NULL
H.	NULL
Lichenstein	NULL
,	NULL
R.	NULL
Bach	NULL
,	NULL
and	NULL
C.	NULL
F.	NULL
Moldow	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
.	NULL

LPS	NULL
Activation	NULL
of	NULL
NF-kB	NULL
Is	NULL
Tyrosine	NULL
Kinase-independent	NULL
ACT	NULL
CHX	NULL
DEX	NULL
M	NULL
L	NULL
M	NULL
L	NULL
M	NULL
L	NULL
M	NULL
L	NULL
wo	NULL
__	NULL
by	NULL
_	NULL
to	NULL
_	NULL
6	NULL
bad	NULL
ﬂuuuu	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Inhibitors	NULL
of	NULL
transcription	NULL
and	NULL
translation	NULL
did	NULL
not	NULL
block	NULL
LPS	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

CHO/CD14	NULL
or	NULL
RAW	NULL
cells	NULL
were	NULL
pretreated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
a	NULL
1	NULL
um	NULL
concentration	NULL
of	NULL
either	NULL
actinomycin	NULL
D	NULL
(	NULL
ACT	NULL
)	NULL
,	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
,	NULL
or	NULL
dexamethasone	NULL
(	NULL
DEX	NULL
)	NULL
.	NULL

This	NULL
treatment	NULL
was	NULL
shown	NULL
to	NULL
inhibit	NULL
LPS-induced	NULL
release	NULL
of	NULL
arachidonate	NULL
from	NULL
both	NULL
CHO/	NULL
CD14	NULL
and	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
either	NULL
800	NULL
ul	NULL
of	NULL
Ham	NULL
's	NULL
F-12	NULL
supplemented	NULL
with	NULL
2	NULL
%	NULL
heat-inactivated	NULL
human	NULL
serum	NULL
(	NULL
M	NULL
)	NULL
or	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
LPS	NULL
suspended	NULL
in	NULL
complete	NULL
medium	NULL
at	NULL
10	NULL
ng/ml	NULL
(	NULL
L	NULL
)	NULL
was	NULL
added	NULL
.	NULL

After	NULL
60	NULL
min	NULL
of	NULL
stimulation	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
and	NULL
autoradiography	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

CHO/CDI4	NULL
RAW	NULL
ng/ml	NULL
LPS	NULL
for	NULL
1	NULL
h	NULL
,	NULL
lysed	NULL
with	NULL
Triton	NULL
X-100	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
using	NULL
the	NULL
anti-phosphotyrosine	NULL
mAb	NULL
4G10	NULL
(	NULL
Fig	NULL
.	NULL

5a	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
CHO/NEO	NULL
did	NULL
not	NULL
demonstrate	NULL
TK	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
treatment	NULL
.	NULL

CHO/CD14	NULL
cells	NULL
also	NULL
failed	NULL
to	NULL
demonstrate	NULL
LPS-inducible	NULL
TK	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
treatment	NULL
of	NULL
CHO/CD14	NULL
cells	NULL
with	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
resulted	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
phosphotyrosine	NULL
residues	NULL
in	NULL
a	NULL
low	NULL
molecular	NULL
mass	NULL
protein	NULL
(	NULL
~40	NULL
kDa	NULL
)	NULL
,	NULL
demonstrating	NULL
that	NULL
the	NULL
anti-phosphotyrosine	NULL
mAb	NULL
recognized	NULL
phosphotyrosine	NULL
residues	NULL
from	NULL
CHO	NULL
cells	NULL
.	NULL

Even	NULL
using	NULL
short	NULL
periods	NULL
of	NULL
treatment	NULL
(	NULL
30	NULL
s	NULL
)	NULL
we	NULL
failed	NULL
to	NULL
observe	NULL
inducible	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
the	NULL
CHO/CD14	NULL
cells	NULL
stimulated	NULL
by	NULL
LPS	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
CHO/	NULL
CD14	NULL
cells	NULL
,	NULL
we	NULL
reproducibly	NULL
observed	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
the	NULL
presence	NULL
of	NULL
three	NULL
proteins	NULL
(	NULL
~40-47	NULL
kDa	NULL
)	NULL
that	NULL
contain	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
upon	NULL
LPS	NULL
stimulation	NULL
.	NULL

An	NULL
alternative	NULL
method	NULL
of	NULL
examining	NULL
LPS-stimulated	NULL
CHO/	NULL
CD14	NULL
transfectants	NULL
for	NULL
inducible	NULL
TK	NULL
activity	NULL
is	NULL
the	NULL
solid	NULL
phase	NULL
immunoprecipitation	NULL
and	NULL
kinase	NULL
assay	NULL
(	NULL
18	NULL
,	NULL
26	NULL
)	NULL
.	NULL

This	NULL
technique	NULL
has	NULL
been	NULL
employed	NULL
recently	NULL
by	NULL
Stefanova	NULL
and	NULL
colleagues	NULL
to	NULL
describe	NULL
CD14-associated	NULL
tyrosine	NULL
kinases	NULL
in	NULL
LPS-stimulated	NULL
human	NULL
monocytes	NULL
(	NULL
18	NULL
)	NULL
.	NULL

These	NULL
authors	NULL
reported	NULL
that	NULL
LPS	NULL
activated	NULL
the	NULL
nonreceptor	NULL
tyrosine	NULL
kinases	NULL
p56	NULL
``	NULL
,	NULL
p58*	NULL
``	NULL
*	NULL
,	NULL
and	NULL
p59	NULL
``	NULL
.	NULL

Furthermore	NULL
,	NULL
p56	NULL
``	NULL
``	NULL
was	NULL
apparently	NULL
associated	NULL
with	NULL
CD14	NULL
:	NULL
immunoprecipitation	NULL
of	NULL
stimulated	NULL
monocytes	NULL
with	NULL
anti-CD14	NULL
mAb	NULL
resulted	NULL
in	NULL
the	NULL
coimmunoprecipitation	NULL
of	NULL
activated	NULL
p56	NULL
``	NULL
``	NULL
.	NULL

When	NULL
CHO/NEO	NULL
and	NULL
CHO/CD14	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
LPS	NULL
for	NULL
15	NULL
min	NULL
and	NULL
subsequently	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
anti-CD14	NULL
mAb	NULL
,	NULL
no	NULL
CD14-associated	NULL
LPS-inducible	NULL
phosphotyrosine	NULL
residues	NULL
were	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

5b	NULL
,	NULL
first	NULL
four	NULL
lanes	NULL
,	NULL
from	NULL
left	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
the	NULL
CHO	NULL
transfectants	NULL
at	NULL
5	NULL
,	NULL
30	NULL
,	NULL
and	NULL
60	NULL
min	NULL
of	NULL
LPS	NULL
stimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
when	NULL
vitamin	NULL
D	NULL
,	NULL
-differentiated	NULL
THP-1	NULL
cells	NULL
(	NULL
a	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
anti-CD14	NULL
mAb	NULL
(	NULL
MY4	NULL
)	NULL
,	NULL
CD14-associated	NULL
kinase	NULL
activity	NULL
was	NULL
observed	NULL
at	NULL
75-80	NULL
,	NULL
53/56	NULL
,	NULL
30	NULL
,	NULL
and	NULL
25	NULL
kDa	NULL
(	NULL
Fig	NULL
.	NULL

5b	NULL
,	NULL
fifth	NULL
and	NULL
sixth	NULL
lanes	NULL
)	NULL
.	NULL

When	NULL
isotype-matched	NULL
control	NULL
antibodies	NULL
were	NULL
used	NULL
,	NULL
no	NULL
kinase	NULL
activity	NULL
was	NULL
observed	NULL
from	NULL
any	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Simultaneous	NULL
immuno-precipitations	NULL
with	NULL
anti-lyn	NULL
antibodies	NULL
(	NULL
«	NULL
-lyn	NULL
)	NULL
presumptively	NULL
identified	NULL
the	NULL
53/56-kDa	NULL
residues	NULL
as	NULL
p56	NULL
``	NULL
(	NULL
Fig	NULL
.	NULL

5b	NULL
,	NULL
seventh	NULL
and	NULL
eighth	NULL
lanes	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
observations	NULL
of	NULL
Stefanova	NULL
et	NULL
al	NULL
.	NULL

(	NULL
18	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
we	NULL
confirmed	NULL
that	NULL
LPS-inducible	NULL
activation	NULL
of	NULL
a	NULL
CD14-associated	NULL
TK	NULL
occurred	NULL
in	NULL
monocytes	NULL
,	NULL
this	NULL
activity	NULL
was	NULL
not	NULL
necessary	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
.	NULL

LPS	NULL
stimulation	NULL
of	NULL
CD14-transfected	NULL
CHO	NULL
cells	NULL
was	NULL
not	NULL
associated	NULL
with	NULL
activation	NULL
of	NULL
any	NULL
CD14-associated	NULL
TK	NULL
under	NULL
conditions	NULL
that	NULL
result	NULL
in	NULL
NF-kB	NULL
translocation	NULL
.	NULL

To	NULL
assess	NULL
further	NULL
the	NULL
requirement	NULL
for	NULL
TK	NULL
activity	NULL
in	NULL
LPS-induced	NULL
CD14-dependent	NULL
signaling	NULL
,	NULL
we	NULL
assayed	NULL
TK	NULL
and	NULL
NF-kB	NULL
22257	NULL
a	NULL
LPS	NULL
|	NULL
-	NULL
1	NULL
§	NULL
0150	NULL
-|	NULL
-	NULL
15	NULL
-	NULL
|	NULL
-	NULL
15	NULL
PMA	NULL
|	NULL
-	NULL
-	NULL
>	NULL
-	NULL
>	NULL
-	NULL
15	NULL
]	NULL
-	NULL
>	NULL
-	NULL
15	NULL
|	NULL
-	NULL
-15	NULL
|M	NULL
106	NULL
(	NULL
kD	NULL
)	NULL
80	NULL
W|	NULL
49	NULL
be	NULL
32.5	NULL
27.5	NULL
CHO/CD14	NULL
CHO/NEO	NULL
_	NULL
RAW	NULL
b	NULL
MY4	NULL
lyn	NULL
7r—	NULL
``	NULL
CHO/neo	NULL
CHO/CD14	NULL
Lo	NULL
e	NULL
E-	NULL
+	NULL
-o	NULL
4	NULL
``	NULL
~	NULL
4	NULL
o-	NULL
'	NULL
ReLPS	NULL
(	NULL
iug/ml	NULL
)	NULL
+	NULL
140	NULL
kDa	NULL
+	NULL
87	NULL
kDa	NULL
m	NULL
-	NULL
48	NULL
kDa	NULL
®	NULL
#	NULL
-	NULL
33	NULL
kDa	NULL
vag	NULL
(	NULL
*	NULL
-	NULL
29	NULL
kDa	NULL
(	NULL
antics	NULL
ANBHA	NULL
80m	NULL
:	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

LPS	NULL
failed	NULL
to	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
CHO/	NULL
CD14	NULL
cells	NULL
.	NULL

Panel	NULL
a	NULL
,	NULL
monolayers	NULL
containing	NULL
2-3	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
either	NULL
100	NULL
ng	NULL
LPS/ml	NULL
or	NULL
30	NULL
ng	NULL
of	NULL
phorbol	NULL
12-myristate	NULL
13-acetate/ml	NULL
in	NULL
Ham	NULL
's	NULL
F-12	NULL
medium	NULL
supplemented	NULL
with	NULL
2	NULL
%	NULL
human	NULL
serum	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
(	NULL
in	NULL
min	NULL
)	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
using	NULL
detergent	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
protease	NULL
and	NULL
phos-phatase	NULL
inhibitors	NULL
,	NULL
size	NULL
fractionated	NULL
by	NULL
SDS-polyacrylamide	NULL
electrophoresis	NULL
on	NULL
a	NULL
6	NULL
%	NULL
gel	NULL
,	NULL
then	NULL
blotted	NULL
to	NULL
nitrocellulose	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
4G10	NULL
anti-phosphotyrosine	NULL
mAb	NULL
and	NULL
a	NULL
horseradish	NULL
peroxidase-based	NULL
chemiluminescence	NULL
system	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
lane	NULL
marked	NULL
M	NULL
contained	NULL
prestained	NULL
molecular	NULL
mass	NULL
markers	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

The	NULL
bracket	NULL
indicates	NULL
the	NULL
region	NULL
of	NULL
the	NULL
gel	NULL
where	NULL
proteins	NULL
that	NULL
have	NULL
been	NULL
modified	NULL
by	NULL
LPS-inducible	NULL
tyrosine	NULL
phosphorylation	NULL
migrate	NULL
.	NULL

Panel	NULL
b	NULL
,	NULL
solid	NULL
phase	NULL
immunoprecipitation	NULL
of	NULL
CD14-associated	NULL
protein	NULL
kinases	NULL
:	NULL
CHO/NEO	NULL
,	NULL
CHO/	NULL
CD14	NULL
,	NULL
or	NULL
vitamin	NULL
D	NULL
,	NULL
-differentiated	NULL
THP-1	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
1	NULL
ug	NULL
of	NULL
LPS/ml	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
the	NULL
solid	NULL
phase	NULL
immunoprecipitation	NULL
and	NULL
kinase	NULL
assay	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
``	NULL
using	NULL
antibody	NULL
against	NULL
CD14	NULL
(	NULL
MY4	NULL
)	NULL
or	NULL
lyn	NULL
(	NULL
«	NULL
-lyn	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
followed	NULL
by	NULL
autoradiography	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
molecular	NULL
mass	NULL
standards	NULL
(	NULL
in	NULL
kDa	NULL
)	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

activation	NULL
in	NULL
cells	NULL
pretreated	NULL
with	NULL
the	NULL
TK	NULL
antagonists	NULL
,	NULL
herbimycin	NULL
A	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
and	NULL
genistein	NULL
(	NULL
100	NULL
um	NULL
)	NULL
.	NULL

CHO/CD14	NULL
and	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
TK	NULL
inhibitors	NULL
for	NULL
4	NULL
h	NULL
prior	NULL
to	NULL
stimulation	NULL
with	NULL
LPS	NULL
.	NULL

Immunoblots	NULL
were	NULL
performed	NULL
with	NULL
cellular	NULL
extracts	NULL
prepared	NULL
from	NULL
RAW	NULL
264.7	NULL
cells	NULL
pretreated	NULL
with	NULL
TK	NULL
antagonists	NULL
prior	NULL
to	NULL
stimulation	NULL
with	NULL
LPS	NULL
,	NULL
to	NULL
assess	NULL
the	NULL
ability	NULL
of	NULL
these	NULL
agents	NULL
to	NULL
block	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Both	NULL
herbimycin	NULL
A	NULL
and	NULL
genistein	NULL
were	NULL
effective	NULL
at	NULL
inhibiting	NULL
LPS-inducible	NULL
TK	NULL
activity	NULL
in	NULL
RAW	NULL
264.7	NULL
macrophage-like	NULL
cells	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
inducible	NULL
phosphotyrosine	NULL
residues	NULL
in	NULL
cellular	NULL
proteins	NULL
following	NULL
stimulation	NULL
with	NULL
LPS	NULL
,	NULL
demonstrating	NULL
the	NULL
effectiveness	NULL
of	NULL
the	NULL
TK	NULL
antagonists	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Herbimycin	NULL
A	NULL
and	NULL
genistein	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
LPS	NULL
to	NULL
induce	NULL
NF-kB	NULL
translocation	NULL
in	NULL
either	NULL
CHO/	NULL
CD14	NULL
or	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
ap-	NULL
22258	NULL
Her	NULL
(	NULL
ng/m	NULL
)	NULL
Gen	NULL
(	NULL
uM	NULL
)	NULL
5	NULL
5	NULL
100	NULL
100	NULL
eae	NULL
-o	NULL
+	NULL
u	NULL
ﬂ	NULL
.	NULL

‘	NULL
.ICHO/CD14	NULL
LPS	NULL
(	NULL
10	NULL
ng/m	NULL
]	NULL
)	NULL
f	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Effect	NULL
of	NULL
TK	NULL
inhibitors	NULL
on	NULL
LPS	NULL
activation	NULL
of	NULL
NF-KB	NULL
.	NULL

Cells	NULL
were	NULL
pretreated	NULL
with	NULL
the	NULL
TK	NULL
antagonists	NULL
,	NULL
herbimycin	NULL
A	NULL
(	NULL
Her	NULL
,	NULL
5	NULL
ug/ml	NULL
)	NULL
or	NULL
genistein	NULL
(	NULL
Gen	NULL
,	NULL
100	NULL
um	NULL
)	NULL
for	NULL
4	NULL
h	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
hour	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
10	NULL
ng	NULL
of	NULL
LPS/ml	NULL
in	NULL
Ham	NULL
's	NULL
F-12	NULL
supplemented	NULL
with	NULL
2	NULL
%	NULL
human	NULL
serum	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Scanning	NULL
densitometry	NULL
of	NULL
the	NULL
autoradiographs	NULL
showed	NULL
that	NULL
the	NULL
ratio	NULL
of	NULL
nuclear	NULL
NF-kB	NULL
in	NULL
stimulated/unstimulated	NULL
cells	NULL
was	NULL
CHO/CD14	NULL
:	NULL
3.6	NULL
,	NULL
13	NULL
,	NULL
and	NULL
4.8	NULL
;	NULL
RAW	NULL
:	NULL
8.1	NULL
,	NULL
10.9	NULL
,	NULL
and	NULL
2.2	NULL
(	NULL
no	NULL
inhibitor	NULL
,	NULL
plus	NULL
herbimycin	NULL
A	NULL
,	NULL
and	NULL
plus	NULL
genistein	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

peared	NULL
to	NULL
proceed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TK	NULL
activity	NULL
in	NULL
both	NULL
CHO/	NULL
CD14	NULL
and	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

Effect	NULL
of	NULL
Erbstatin	NULL
Analog	NULL
,	NULL
a	NULL
TK	NULL
Antagonist	NULL
,	NULL
on	NULL
Basal	NULL
NF-kB	NULL
Levels-Pretreatment	NULL
of	NULL
either	NULL
CHO/CD14	NULL
or	NULL
RAW	NULL
264.7	NULL
cells	NULL
with	NULL
erbstatin	NULL
analog	NULL
resulted	NULL
in	NULL
a	NULL
time-dependent	NULL
decrease	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
present	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
resting	NULL
and	NULL
LPS-stimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
basal	NULL
levels	NULL
of	NULL
NF-kB	NULL
also	NULL
were	NULL
diminished	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
erbstatin	NULL
analog	NULL
suggested	NULL
that	NULL
the	NULL
drug	NULL
might	NULL
cause	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
cellular	NULL
pools	NULL
of	NULL
NF-kB	NULL
.	NULL

Thus	NULL
,	NULL
its	NULL
ability	NULL
to	NULL
block	NULL
LPS-induced	NULL
activation	NULL
of	NULL
NF-kB	NULL
was	NULL
unrelated	NULL
to	NULL
transmembrane	NULL
signaling	NULL
.	NULL

Alternatively	NULL
,	NULL
erbstatin	NULL
analog	NULL
might	NULL
actually	NULL
inhibit	NULL
the	NULL
LPS	NULL
signal	NULL
transduction	NULL
machinery	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
cellular	NULL
NF-kB	NULL
.	NULL

To	NULL
distinguish	NULL
between	NULL
these	NULL
two	NULL
possibilities	NULL
,	NULL
we	NULL
prepared	NULL
cytosolic	NULL
extracts	NULL
from	NULL
either	NULL
untreated	NULL
RAW	NULL
264.7	NULL
cells	NULL
or	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
treated	NULL
with	NULL
erbstatin	NULL
analog	NULL
for	NULL
1	NULL
h.	NULL
Cytoplasmic	NULL
extracts	NULL
were	NULL
treated	NULL
sequentially	NULL
with	NULL
deoxycholate	NULL
and	NULL
Nonidet	NULL
P-40	NULL
and	NULL
then	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

Treating	NULL
cytoplasmic	NULL
extracts	NULL
with	NULL
deoxycholate	NULL
followed	NULL
by	NULL
Nonidet	NULL
P-40	NULL
effectively	NULL
dissociates	NULL
heterodimeric	NULL
complexes	NULL
of	NULL
NF-kB	NULL
from	NULL
their	NULL
inhibitory	NULL
subunits	NULL
(	NULL
e.g	NULL
.	NULL

IxB	NULL
)	NULL
,	NULL
allowing	NULL
NF-kB	NULL
to	NULL
bind	NULL
specifically	NULL
to	NULL
DNA	NULL
probes	NULL
in	NULL
vitro	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Deoxycholate/Nonidet	NULL
P-40	NULL
treatment	NULL
of	NULL
cytosolic	NULL
extracts	NULL
from	NULL
cells	NULL
that	NULL
had	NULL
not	NULL
been	NULL
treated	NULL
with	NULL
erbstatin	NULL
analog	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
significant	NULL
quantities	NULL
of	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
prepared	NULL
from	NULL
RAW	NULL
264.7	NULL
cells	NULL
treated	NULL
with	NULL
erbstatin	NULL
analog	NULL
for	NULL
1	NULL
h	NULL
contained	NULL
dramatically	NULL
reduced	NULL
levels	NULL
of	NULL
NF-kB	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
deoxycholate/Nonidet	NULL
P-40	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
also	NULL
observed	NULL
using	NULL
CHO/CD14	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
apparent	NULL
ability	NULL
of	NULL
erbstatin	NULL
analog	NULL
to	NULL
inhibit	NULL
LPS-induced	NULL
activation	NULL
of	NULL
NF-kB	NULL
was	NULL
not	NULL
the	NULL
result	NULL
of	NULL
inhibition	NULL
of	NULL
LPS-induced	NULL
signal	NULL
transduction	NULL
.	NULL

Rather	NULL
,	NULL
pretreatment	NULL
of	NULL
cells	NULL
with	NULL
erbstatin	NULL
analog	NULL
caused	NULL
the	NULL
elimination	NULL
of	NULL
functional	NULL
NF-kB	NULL
from	NULL
cellular	NULL
pools	NULL
.	NULL

DISCUSSION	NULL
The	NULL
discovery	NULL
that	NULL
LBP-complexed	NULL
LPS	NULL
can	NULL
activate	NULL
cells	NULL
by	NULL
interacting	NULL
directly	NULL
with	NULL
CD14	NULL
was	NULL
a	NULL
fundamental	NULL
breakthrough	NULL
in	NULL
understanding	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
endotoxin	NULL
activates	NULL
monocytes	NULL
,	NULL
macrophages	NULL
,	NULL
and	NULL
neutrophils	NULL
.	NULL

The	NULL
results	NULL
of	NULL
CD14	NULL
transfection	NULL
experiments	NULL
(	NULL
9	NULL
,	NULL
12	NULL
,	NULL
16	NULL
,	NULL
35	NULL
)	NULL
imply	NULL
that	NULL
proteins	NULL
required	NULL
for	NULL
LPS	NULL
signal	NULL
transduction	NULL
,	NULL
subsequent	NULL
to	NULL
ligand	NULL
binding	NULL
by	NULL
CD14	NULL
,	NULL
are	NULL
widespread	NULL
and	NULL
not	NULL
limited	NULL
to	NULL
LPS	NULL
Activation	NULL
of	NULL
NF-kB	NULL
Is	NULL
Tyrosine	NULL
Kinase-independent	NULL
LPS	NULL
|	NULL
-|-	NULL
|	NULL
-	NULL
|	NULL
-	NULL
[	NULL
+	NULL
[	NULL
+/+	NULL
/+	NULL
Erb	NULL
an|	NULL
0	NULL
|	NULL
1	NULL
|	NULL
2	NULL
0	NULL
|1	NULL
]	NULL
|2	NULL
]	NULL
3	NULL
|	NULL
0	NULL
|	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
%	NULL
10	NULL
Lane	NULL
1	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Erbstatin	NULL
analog	NULL
eliminated	NULL
NF-	NULL
«	NULL
B	NULL
cytosolic	NULL
pools	NULL
from	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

Cell	NULL
monolayers	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
um	NULL
erbstatin	NULL
analog	NULL
in	NULL
complete	NULL
medium	NULL
for	NULL
increasing	NULL
periods	NULL
of	NULL
time	NULL
and	NULL
incubated	NULL
an	NULL
additional	NULL
hour	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
10	NULL
ng	NULL
of	NULL
LPS/ml	NULL
.	NULL

The	NULL
time	NULL
with	NULL
which	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
erbstatin	NULL
analog	NULL
prior	NULL
to	NULL
LPS	NULL
stimulation	NULL
is	NULL
indicated	NULL
in	NULL
hours	NULL
above	NULL
the	NULL
corresponding	NULL
lane	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
lanes	NULL
1-8	NULL
)	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
``	NULL
except	NULL
that	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
100	NULL
ul	NULL
of	NULL
buffer	NULL
I	NULL
prior	NULL
to	NULL
analysis	NULL
by	NULL
EMSA	NULL
.	NULL

Cytoplasmic	NULL
fractions	NULL
from	NULL
unstimulated	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
were	NULL
reserved	NULL
from	NULL
the	NULL
same	NULL
cells	NULL
used	NULL
to	NULL
prepare	NULL
the	NULL
nuclear	NULL
extracts	NULL
shown	NULL
in	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
dialyzed	NULL
against	NULL
10,000	NULL
volumes	NULL
of	NULL
buffer	NULL
II	NULL
(	NULL
see	NULL
``	NULL
Materials	NULL
and	NULL
Meth-ods	NULL
``	NULL
)	NULL
for	NULL
12	NULL
h.	NULL
The	NULL
extracts	NULL
were	NULL
adjusted	NULL
to	NULL
0.1	NULL
%	NULL
deoxycholate	NULL
(	NULL
v/v	NULL
)	NULL
,	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
,	NULL
then	NULL
supplemented	NULL
with	NULL
Nonidet	NULL
P-40	NULL
to	NULL
0.1	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
an	NULL
additional	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
before	NULL
subjecting	NULL
to	NULL
EMSA	NULL
.	NULL

Lanes	NULL
containing	NULL
nuclear	NULL
extracts	NULL
(	NULL
lanes	NULL
1-8	NULL
)	NULL
were	NULL
exposed	NULL
to	NULL
film	NULL
overnight	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
at	NULL
-80	NULL
°C	NULL
;	NULL
lanes	NULL
containing	NULL
cytoplasmic	NULL
extracts	NULL
(	NULL
Zanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
were	NULL
exposed	NULL
to	NULL
film	NULL
for	NULL
5	NULL
days	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

Virtually	NULL
identical	NULL
results	NULL
were	NULL
seen	NULL
when	NULL
cells	NULL
were	NULL
pretreated	NULL
10	NULL
um	NULL
erbstatin	NULL
analog	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

myeloid	NULL
cells	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
rapidly	NULL
translocated	NULL
in	NULL
macrophages	NULL
following	NULL
stimulation	NULL
with	NULL
endotoxin	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
treatment	NULL
of	NULL
CHO/CD14	NULL
cells	NULL
with	NULL
low	NULL
concentrations	NULL
of	NULL
LPS	NULL
induced	NULL
rapid	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
.	NULL

This	NULL
response	NULL
is	NULL
an	NULL
early	NULL
signaling	NULL
event	NULL
and	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
require	NULL
transcription	NULL
or	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
.	NULL

Furthermore	NULL
,	NULL
TK	NULL
activity	NULL
apparently	NULL
was	NULL
not	NULL
required	NULL
to	NULL
observe	NULL
NF-kB	NULL
translocation	NULL
in	NULL
transfected	NULL
cells	NULL
as	NULL
evidenced	NULL
by	NULL
immunoblotting	NULL
lysates	NULL
with	NULL
anti-phosphotyrosine	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
or	NULL
pharmacologic	NULL
analysis	NULL
of	NULL
both	NULL
CHO/CD14	NULL
and	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
LPS	NULL
in	NULL
conjunction	NULL
with	NULL
soluble	NULL
CD14	NULL
did	NULL
not	NULL
induce	NULL
NF-kB	NULL
activation	NULL
in	NULL
wild-type	NULL
CHO-K1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Ciliary	NULL
neurotrophic	NULL
factor	NULL
(	NULL
CNTF	NULL
)	NULL
-induced	NULL
signal	NULL
transduction	NULL
may	NULL
provide	NULL
the	NULL
best	NULL
model	NULL
for	NULL
the	NULL
study	NULL
of	NULL
cell	NULL
signaling	NULL
by	NULL
glycosylphosphatidylinositol-linked	NULL
proteins	NULL
.	NULL

In	NULL
this	NULL
signaling	NULL
system	NULL
,	NULL
CNTF	NULL
binds	NULL
the	NULL
glycosylphosphatidylinositol-an-chored	NULL
«	NULL
component	NULL
(	NULL
CNTFR-	NULL
«	NULL
)	NULL
of	NULL
the	NULL
CNTF	NULL
receptor	NULL
causing	NULL
CNTFR-	NULL
«	NULL
to	NULL
bind	NULL
sequentially	NULL
to	NULL
the	NULL
B	NULL
component	NULL
of	NULL
the	NULL
leukemia	NULL
inhibitory	NULL
factor	NULL
receptor	NULL
and	NULL
gp130	NULL
.	NULL

Similarly	NULL
,	NULL
binding	NULL
of	NULL
interleukin-6	NULL
to	NULL
its	NULL
soluble	NULL
receptor	NULL
is	NULL
followed	NULL
by	NULL
the	NULL
association	NULL
of	NULL
this	NULL
complex	NULL
to	NULL
a	NULL
dimer	NULL
of	NULL
gp130	NULL
and	NULL
results	NULL
in	NULL
signal	NULL
transduction	NULL
.	NULL

Another	NULL
variant	NULL
of	NULL
this	NULL
signaling	NULL
paradigm	NULL
is	NULL
signal	NULL
transduction	NULL
in	NULL
response	NULL
to	NULL
leukemia	NULL
inhibitory	NULL
factor	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
leukemia	NULL
inhibitory	NULL
factor	NULL
receptor-B	NULL
,	NULL
an	NULL
integral	NULL
protein	NULL
on	NULL
responsive	NULL
cells	NULL
,	NULL
inducing	NULL
heterodimerization	NULL
with	NULL
gp130	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
two	NULL
subunits	NULL
,	NULL
and	NULL
signal	NULL
transduction	NULL
(	NULL
36	NULL
)	NULL
.	NULL

In	NULL
each	NULL
signal	NULL
transduction	NULL
system	NULL
described	NULL
above	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
transmembrane	NULL
subunits	NULL
occurs	NULL
concomitantly	NULL
with	NULL
dimerization	NULL
or	NULL
tri-merization	NULL
of	NULL
the	NULL
receptor	NULL
complexes	NULL
.	NULL

Signal	NULL
transduction	NULL
across	NULL
the	NULL
membrane	NULL
is	NULL
observed	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
subsequent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
low	NULL
molecular	NULL
mass	NULL
cellular	NULL
proteins	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
specificity	NULL
of	NULL
the	NULL
gp130	NULL
signal-transducing	NULL
molecule	NULL
is	NULL
conferred	NULL
by	NULL
accessory	NULL
proteins	NULL
,	NULL
which	NULL
do	NULL
not	NULL
necessarily	NULL
signal	NULL
directly	NULL
,	NULL
but	NULL
are	NULL
required	NULL
for	NULL
proper	NULL
receptor	NULL
function	NULL
.	NULL

LPS	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
Is	NULL
Tyrosine	NULL
Kinase-independent	NULL
Recently	NULL
,	NULL
reports	NULL
have	NULL
suggested	NULL
that	NULL
like	NULL
the	NULL
CNTF	NULL
recep-tor	NULL
,	NULL
CD14	NULL
does	NULL
not	NULL
signal	NULL
directly	NULL
,	NULL
but	NULL
signals	NULL
through	NULL
an	NULL
as	NULL
yet	NULL
unidentified	NULL
signal	NULL
transducing	NULL
protein	NULL
.	NULL

We	NULL
have	NULL
even	NULL
considered	NULL
that	NULL
gp130	NULL
is	NULL
the	NULL
CD14-associated	NULL
signal	NULL
transducer	NULL
,	NULL
but	NULL
experiments	NULL
in	NULL
our	NULL
laboratory	NULL
with	NULL
human	NULL
mononuclear	NULL
cells	NULL
purified	NULL
from	NULL
whole	NULL
blood	NULL
have	NULL
failed	NULL
to	NULL
demonstrate	NULL
that	NULL
anti-gp130	NULL
mAb	NULL
(	NULL
gift	NULL
from	NULL
Drs	NULL
.	NULL

T.	NULL
Taga	NULL
and	NULL
T.	NULL
Kishimoto	NULL
,	NULL
Japan	NULL
)	NULL
inhibit	NULL
LPS-induced	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
release	NULL
.	NULL
``	NULL

In	NULL
light	NULL
of	NULL
the	NULL
CNTF	NULL
model	NULL
,	NULL
the	NULL
rapid	NULL
appearance	NULL
of	NULL
TK	NULL
activity	NULL
observed	NULL
following	NULL
exposure	NULL
to	NULL
endotoxin	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
,	NULL
human	NULL
monocytes	NULL
(	NULL
15	NULL
,	NULL
18	NULL
)	NULL
,	NULL
and	NULL
CD14-transfected	NULL
702/3	NULL
lym-phocytes	NULL
(	NULL
16	NULL
)	NULL
suggested	NULL
that	NULL
this	NULL
putative	NULL
signal	NULL
transducing	NULL
protein	NULL
may	NULL
function	NULL
by	NULL
activating	NULL
a	NULL
TK	NULL
cascade	NULL
.	NULL

We	NULL
were	NULL
unable	NULL
to	NULL
demonstrate	NULL
LPS-inducible	NULL
TK	NULL
activity	NULL
by	NULL
immunoblotting	NULL
protein	NULL
extracts	NULL
from	NULL
LPS-treated	NULL
CHO/CD14	NULL
cells	NULL
whereas	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
induced	NULL
a	NULL
distinct	NULL
pattern	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

5a	NULL
)	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
a	NULL
TK	NULL
event	NULL
was	NULL
not	NULL
required	NULL
for	NULL
LPS-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
CHO/CD14	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
considered	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
immunoblot	NULL
assay	NULL
lacked	NULL
the	NULL
sensitivity	NULL
required	NULL
to	NULL
detect	NULL
LPS-induced	NULL
TK	NULL
activation	NULL
in	NULL
CHO/CD14	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
putative	NULL
CD14-related	NULL
signal-transducing	NULL
element	NULL
nevertheless	NULL
might	NULL
be	NULL
a	NULL
TK	NULL
.	NULL

However	NULL
,	NULL
our	NULL
observations	NULL
that	NULL
pretreatment	NULL
of	NULL
CHO/CD14	NULL
cells	NULL
or	NULL
murine	NULL
macrophages	NULL
with	NULL
genistein	NULL
and	NULL
herbimycin	NULL
A	NULL
did	NULL
not	NULL
inhibit	NULL
LPS-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
coupled	NULL
with	NULL
the	NULL
immunoblot	NULL
data	NULL
further	NULL
suggest	NULL
that	NULL
this	NULL
signal	NULL
transduction	NULL
pathway	NULL
does	NULL
not	NULL
require	NULL
TK	NULL
activity	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
CHO/CD14	NULL
and	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

Although	NULL
it	NULL
might	NULL
appear	NULL
that	NULL
the	NULL
TK	NULL
inhibitors	NULL
had	NULL
some	NULL
inhibitory	NULL
effect	NULL
on	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
levels	NULL
in	NULL
LPS-stimulated	NULL
cells	NULL
,	NULL
basal	NULL
levels	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
present	NULL
in	NULL
CHO/CD14	NULL
and	NULL
RAW	NULL
264.7	NULL
cells	NULL
pretreated	NULL
with	NULL
either	NULL
herbimycin	NULL
A	NULL
or	NULL
genistein	NULL
were	NULL
decreased	NULL
relative	NULL
to	NULL
untreated	NULL
control	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Our	NULL
experimental	NULL
results	NULL
,	NULL
as	NULL
well	NULL
as	NULL
those	NULL
presented	NULL
by	NULL
others	NULL
(	NULL
e.g	NULL
.	NULL

see	NULL
Fig	NULL
.	NULL

6b	NULL
in	NULL
Ref	NULL
.	NULL

16	NULL
)	NULL
may	NULL
reflect	NULL
the	NULL
ability	NULL
of	NULL
some	NULL
TK	NULL
inhibitors	NULL
to	NULL
decrease	NULL
overall	NULL
levels	NULL
of	NULL
NF-kB	NULL
through	NULL
their	NULL
effects	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
synthesis	NULL
or	NULL
stability	NULL
.	NULL

The	NULL
apparent	NULL
inhibitory	NULL
effects	NULL
of	NULL
TK	NULL
inhibitors	NULL
on	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
levels	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
reflect	NULL
a	NULL
requirement	NULL
for	NULL
TK	NULL
activity	NULL
for	NULL
signal	NULL
transduction	NULL
to	NULL
occur	NULL
.	NULL

We	NULL
present	NULL
data	NULL
here	NULL
that	NULL
CHO/CD14	NULL
cells	NULL
do	NULL
not	NULL
respond	NULL
to	NULL
LPS	NULL
stimulation	NULL
by	NULL
activating	NULL
TK	NULL
using	NULL
three	NULL
established	NULL
ap-proaches	NULL
.	NULL

First	NULL
,	NULL
inducible	NULL
phosphotyrosine	NULL
residues	NULL
are	NULL
not	NULL
observed	NULL
by	NULL
Western	NULL
blot	NULL
.	NULL

Second	NULL
,	NULL
in	NULL
vitro	NULL
kinase	NULL
assays	NULL
fail	NULL
to	NULL
show	NULL
receptor-associated	NULL
TK	NULL
activity	NULL
.	NULL

Finally	NULL
,	NULL
TK	NULL
inhibitors	NULL
fail	NULL
to	NULL
block	NULL
an	NULL
LPS-inducible	NULL
response	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
CNTF	NULL
receptor	NULL
paradigm	NULL
may	NULL
not	NULL
apply	NULL
directly	NULL
to	NULL
CD14-mediated	NULL
signaling	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
signaling	NULL
pathways	NULL
other	NULL
than	NULL
those	NULL
that	NULL
culminate	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
,	NULL
such	NULL
as	NULL
those	NULL
that	NULL
result	NULL
in	NULL
the	NULL
production	NULL
of	NULL
certain	NULL
inflammatory	NULL
mediators	NULL
,	NULL
may	NULL
indeed	NULL
require	NULL
TK	NULL
activity	NULL
.	NULL

Macrophages	NULL
possess	NULL
a	NULL
large	NULL
repertoire	NULL
of	NULL
LPS-inducible	NULL
responses	NULL
,	NULL
and	NULL
these	NULL
pathways	NULL
may	NULL
require	NULL
the	NULL
activity	NULL
of	NULL
nonreceptor	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
activated	NULL
in	NULL
cells	NULL
following	NULL
engagement	NULL
of	NULL
CD14	NULL
with	NULL
LPS	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
TK	NULL
activity	NULL
in	NULL
CHO/CD14	NULL
could	NULL
explain	NULL
the	NULL
small	NULL
number	NULL
of	NULL
macrophage-like	NULL
responses	NULL
acquired	NULL
by	NULL
CHO-K1	NULL
cells	NULL
following	NULL
transfection	NULL
with	NULL
CD14	NULL
.	NULL

Because	NULL
many	NULL
of	NULL
the	NULL
genes	NULL
for	NULL
select	NULL
tyrosine	NULL
kinases	NULL
have	NULL
been	NULL
cloned	NULL
and	NULL
can	NULL
be	NULL
transfected	NULL
in	NULL
CHO	NULL
cells	NULL
,	NULL
this	NULL
hypothesis	NULL
can	NULL
now	NULL
be	NULL
tested	NULL
.	NULL

Several	NULL
recent	NULL
publications	NULL
have	NULL
demonstrated	NULL
that	NULL
soluble	NULL
CD14	NULL
can	NULL
bind	NULL
LPS	NULL
and	NULL
activate	NULL
endothelial	NULL
and	NULL
epithelial	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
LBP	NULL
(	NULL
8	NULL
,	NULL
28-32	NULL
)	NULL
.	NULL

It	NULL
was	NULL
proposed	NULL
that	NULL
rsCD14-LPS	NULL
complexes	NULL
can	NULL
interact	NULL
with	NULL
specific	NULL
receptors	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
these	NULL
cell	NULL
types	NULL
and	NULL
effect	NULL
signal	NULL
transduction	NULL
.	NULL

A	NULL
soluble	NULL
form	NULL
of	NULL
the	NULL
CNTF	NULL
receptor	NULL
a	NULL
component	NULL
was	NULL
shown	NULL
to	NULL
*	NULL
R.	NULL
I.	NULL
Ingalls	NULL
and	NULL
D.	NULL
T.	NULL
Golenbock	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

22259	NULL
activate	NULL
normally	NULL
nonresponsive	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CNTF	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
was	NULL
surprising	NULL
that	NULL
rsCD14	NULL
did	NULL
not	NULL
compensate	NULL
for	NULL
membrane	NULL
bound	NULL
CD14	NULL
in	NULL
CHO-K1	NULL
cells	NULL
.	NULL

This	NULL
result	NULL
was	NULL
probably	NULL
not	NULL
due	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
glycosylphosphatidylinosi-tol	NULL
anchor	NULL
because	NULL
an	NULL
integral	NULL
membrane	NULL
form	NULL
of	NULL
CD14	NULL
functions	NULL
in	NULL
a	NULL
manner	NULL
identical	NULL
with	NULL
the	NULL
glycolipid-anchored	NULL
form	NULL
of	NULL
CD14	NULL
when	NULL
transfected	NULL
into	NULL
702/3	NULL
cells	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Membrane	NULL
attachment	NULL
of	NULL
CD14	NULL
therefore	NULL
might	NULL
be	NULL
a	NULL
unique	NULL
requirement	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
CHO-K1	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Alternatively	NULL
,	NULL
expression	NULL
of	NULL
high	NULL
levels	NULL
of	NULL
CD14	NULL
in	NULL
transfectants	NULL
would	NULL
result	NULL
in	NULL
a	NULL
sufficient	NULL
density	NULL
of	NULL
CD14	NULL
molecules	NULL
on	NULL
the	NULL
plasma	NULL
membrane	NULL
compared	NULL
with	NULL
LPS-activated	NULL
rsCD14	NULL
,	NULL
which	NULL
might	NULL
be	NULL
necessary	NULL
for	NULL
interacting	NULL
with	NULL
additional	NULL
signaling	NULL
molecules	NULL
in	NULL
CHO-K1	NULL
cells	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
association	NULL
of	NULL
LPS	NULL
with	NULL
rsCD14	NULL
is	NULL
time-dependent	NULL
and	NULL
can	NULL
be	NULL
facilitated	NULL
cat-alytically	NULL
by	NULL
LBP	NULL
(	NULL
38	NULL
)	NULL
.	NULL

In	NULL
the	NULL
experiments	NULL
presented	NULL
here	NULL
,	NULL
rsCD14	NULL
and	NULL
LPS	NULL
were	NULL
added	NULL
to	NULL
CHO-K1	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
LBP	NULL
without	NULL
preincubation	NULL
,	NULL
and	NULL
thus	NULL
rsCD14	NULL
and	NULL
LPS	NULL
may	NULL
not	NULL
have	NULL
had	NULL
time	NULL
to	NULL
form	NULL
active	NULL
complexes	NULL
.	NULL

We	NULL
have	NULL
not	NULL
rigorously	NULL
assessed	NULL
this	NULL
kinetic	NULL
issue	NULL
and	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
rsCD14	NULL
might	NULL
enable	NULL
LPS	NULL
responses	NULL
in	NULL
CHO-K1	NULL
cells	NULL
under	NULL
different	NULL
stimulation	NULL
conditions	NULL
.	NULL

Further	NULL
examination	NULL
of	NULL
the	NULL
mechanism	NULL
of	NULL
soluble	NULL
CD14	NULL
is	NULL
beyond	NULL
the	NULL
scope	NULL
of	NULL
this	NULL
paper	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
CHO/CD14	NULL
cells	NULL
respond	NULL
to	NULL
LPS	NULL
by	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
metabolism	NULL
of	NULL
arachidonic	NULL
acid	NULL
is	NULL
strong	NULL
evidence	NULL
that	NULL
signaling	NULL
molecules	NULL
similar	NULL
to	NULL
those	NULL
in	NULL
phagocytes	NULL
are	NULL
present	NULL
in	NULL
CHO/CD14	NULL
cells	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
CHO	NULL
cells	NULL
are	NULL
easily	NULL
manipulated	NULL
and	NULL
efficiently	NULL
transfected	NULL
makes	NULL
the	NULL
CHO/CD14	NULL
cell	NULL
line	NULL
a	NULL
valuable	NULL
tool	NULL
in	NULL
which	NULL
to	NULL
employ	NULL
molecular	NULL
genetic	NULL
analysis	NULL
of	NULL
the	NULL
LPS	NULL
signaling	NULL
pathway	NULL
culminating	NULL
in	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
arachidonic	NULL
acid	NULL
metabolism	NULL
.	NULL

Ultimately	NULL
,	NULL
a	NULL
combination	NULL
of	NULL
genetic	NULL
analysis	NULL
and	NULL
pharmacologic	NULL
approaches	NULL
should	NULL
identify	NULL
the	NULL
family	NULL
of	NULL
LPS	NULL
signaling	NULL
proteins	NULL
which	NULL
can	NULL
subsequently	NULL
be	NULL
targeted	NULL
for	NULL
the	NULL
development	NULL
of	NULL
therapeutic	NULL
agents	NULL
for	NULL
sepsis	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Haziot	NULL
,	NULL
A.	NULL
,	NULL
Chen	NULL
,	NULL
S.	NULL
,	NULL
Ferrero	NULL
,	NULL
E.	NULL
,	NULL
Low	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Silber	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Goyert	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

141	NULL
,	NULL
547-552	NULL
2	NULL
.	NULL

Wright	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Ramos	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

170	NULL
,	NULL
1231-1241	NULL
3	NULL
.	NULL

Tobias	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Soldau	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
,	NULL
.	NULL

164	NULL
,	NULL
777-793	NULL
4	NULL
.	NULL

Wright	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Ramos	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Patel	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Miller	NULL
,	NULL
D.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176	NULL
,	NULL
719-727	NULL
5	NULL
.	NULL

Wright	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Ramos	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Mathison	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
249	NULL
,	NULL
1431-1483	NULL
6	NULL
.	NULL

Schumann	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Leong	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Flaggs	NULL
,	NULL
G.	NULL
W.	NULL
,	NULL
Gray	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
Wright	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Mathison	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
and	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Science	NULL
249	NULL
,	NULL
1429-1431	NULL
7	NULL
.	NULL

Lynn	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
Raetz	NULL
,	NULL
C.	NULL
R.	NULL
H.	NULL
,	NULL
Qureshi	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Golenbock	NULL
,	NULL
D.	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

147	NULL
,	NULL
3072-3079	NULL
8	NULL
.	NULL

Frey	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Miller	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Jahr	NULL
,	NULL
T.	NULL
G.	NULL
,	NULL
Sundan	NULL
,	NULL
A.	NULL
,	NULL
Bazil	NULL
,	NULL
V.	NULL
,	NULL
Espevik	NULL
,	NULL
T.	NULL
,	NULL
Finlay	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Wright	NULL
,	NULL
S.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176	NULL
,	NULL
1665-1671	NULL
9	NULL
.	NULL

Golenbock	NULL
,	NULL
D.	NULL
,	NULL
Liu	NULL
,	NULL
Y.	NULL
,	NULL
Millham	NULL
,	NULL
F.	NULL
,	NULL
Freeman	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Zoeller	NULL
,	NULL
R	NULL
,	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

288	NULL
,	NULL
22055-22059	NULL
10	NULL
.	NULL

Heumann	NULL
,	NULL
D.	NULL
,	NULL
Gallay	NULL
,	NULL
P.	NULL
,	NULL
Barras	NULL
,	NULL
C.	NULL
,	NULL
Zaech	NULL
,	NULL
P.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Glauser	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
and	NULL
Baumgartner	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
3505-3512	NULL
11	NULL
.	NULL

Kitchens	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Munford	NULL
,	NULL
R.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176	NULL
,	NULL
485-494	NULL
12	NULL
.	NULL

Lee	NULL
,	NULL
J.-D.	NULL
,	NULL
Kato	NULL
,	NULL
K.	NULL
,	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Kirkland	NULL
,	NULL
T.	NULL
N.	NULL
,	NULL
and	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
,	NULL
1697-1705	NULL
13	NULL
.	NULL

Weinstein	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Gold	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
DeFranco	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
4148-4152	NULL
14	NULL
,	NULL
Weinstein	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Sanghera	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Lemke	NULL
,	NULL
K.	NULL
,	NULL
DeFranco	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Pelech	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
14955-14962	NULL
15	NULL
.	NULL

Weinstein	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
and	NULL
DeFranco	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
3829-3838	NULL
16	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
Lee	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
and	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
25009-25014	NULL
17	NULL
.	NULL

Manthey	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Qureshi	NULL
,	NULL
N.	NULL
,	NULL
Stutz	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
and	NULL
Vogel	NULL
,	NULL
S.	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178	NULL
,	NULL
695-702	NULL
18	NULL
.	NULL

Stefanova	NULL
,	NULL
L.	NULL
,	NULL
Corcoran	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Horak	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Wahl	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Bolen	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Horak	NULL
,	NULL
I.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
20725-20728	NULL
19	NULL
.	NULL

Muller	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Immunobi-ology	NULL
187	NULL
,	NULL
233-256	NULL
20	NULL
.	NULL

Libermann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2327-2334	NULL
21	NULL
.	NULL

Shakhov	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
Collart	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Vassalli	NULL
,	NULL
P.	NULL
,	NULL
Nedospasov	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
and	NULL
Jongeneel	NULL
,	NULL
C.	NULL
22260	NULL
V.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171	NULL
,	NULL
35-47	NULL
22	NULL
.	NULL

Shimizu	NULL
,	NULL
H.	NULL
,	NULL
Mitomo	NULL
,	NULL
K.	NULL
,	NULL
Watanabe	NULL
,	NULL
T.	NULL
,	NULL
Okamoto	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Yamamoto	NULL
,	NULL
K.	NULL
(	NULL
1990	NULL
)	NULL
23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
561-568	NULL
Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
Hunninghake	NULL
,	NULL
G.	NULL
W.	NULL
,	NULL
Monks	NULL
,	NULL
B.	NULL
G.	NULL
,	NULL
Geist	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Monick	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Monroy	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Stinski	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Webb	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Dayer	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Auron	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
and	NULL
Fenton	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
3439-3448	NULL
Tamura	NULL
,	NULL
G.	NULL
S.	NULL
,	NULL
Dailey	NULL
,	NULL
M.	NULL
O.	NULL
,	NULL
Gallatin	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
McGrath	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Weissman	NULL
,	NULL
I.	NULL
L.	NULL
,	NULL
and	NULL
Pillemer	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

136	NULL
,	NULL
458-464	NULL
Lynn	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
Liu	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Golenbock	NULL
,	NULL
D.	NULL
T	NULL
,	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Infect	NULL
.	NULL

Immun	NULL
.	NULL

61	NULL
,	NULL
4452-4461	NULL
Haziot	NULL
,	NULL
A.	NULL
,	NULL
Rong	NULL
,	NULL
G.	NULL
W.	NULL
,	NULL
Silver	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Goyert	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
1500-1507	NULL
Arditi	NULL
,	NULL
M.	NULL
,	NULL
Zhou	NULL
,	NULL
J.	NULL
,	NULL
Dorio	NULL
,	NULL
R.	NULL
,	NULL
Rong	NULL
,	NULL
G.	NULL
W.	NULL
,	NULL
Goyert	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
Kim	NULL
,	NULL
K.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Infect	NULL
.	NULL

Immun	NULL
.	NULL

61	NULL
,	NULL
3149-3156	NULL
Read	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Cordle	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Veach	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Carlisle	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
and	NULL
Hawiger	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

LPS	NULL
Activation	NULL
of	NULL
NF-kB	NULL
Is	NULL
Tyrosine	NULL
Kinase-independent	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
9887-9891	NULL
Pugin	NULL
,	NULL
J.	NULL
,	NULL
Schurer-Maly	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Leturcq	NULL
,	NULL
D.	NULL
,	NULL
Moriarty	NULL
,	NULL
A.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U	NULL
.	NULL

8	NULL
,	NULL
A	NULL
.	NULL

90	NULL
,	NULL
2744-2748	NULL
Goldblum	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Brann	NULL
,	NULL
T.	NULL
W.	NULL
,	NULL
Ding	NULL
,	NULL
X.	NULL
,	NULL
Pugin	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

98	NULL
,	NULL
692-702	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
211-217	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
242	NULL
,	NULL
540-546	NULL
Lee	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Kravchenks	NULL
,	NULL
V.	NULL
,	NULL
Kirkland	NULL
,	NULL
T.	NULL
N.	NULL
,	NULL
Han	NULL
,	NULL
J.	NULL
,	NULL
Mackman	NULL
,	NULL
N.	NULL
,	NULL
Moriarty	NULL
,	NULL
A.	NULL
,	NULL
Leturcq	NULL
,	NULL
D.	NULL
,	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
and	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
9930-9934	NULL
Davis	NULL
,	NULL
S.	NULL
,	NULL
Aldrich	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
Stahl	NULL
,	NULL
N.	NULL
,	NULL
Pan	NULL
,	NULL
L.	NULL
,	NULL
Taga	NULL
,	NULL
T.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
Ip	NULL
,	NULL
N.	NULL
Y.	NULL
,	NULL
and	NULL
Yancopoulos	NULL
,	NULL
G.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
260	NULL
,	NULL
1805-1808	NULL
Davis	NULL
,	NULL
S.	NULL
,	NULL
Aldrich	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
Ip	NULL
,	NULL
N.	NULL
Y.	NULL
,	NULL
Stahl	NULL
,	NULL
N.	NULL
,	NULL
Scherer	NULL
,	NULL
S.	NULL
,	NULL
Farruggella	NULL
,	NULL
T.	NULL
,	NULL
DiStefano	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Curtis	NULL
,	NULL
R.	NULL
,	NULL
Panayotatos	NULL
,	NULL
N.	NULL
,	NULL
Gascan	NULL
,	NULL
H.	NULL
,	NULL
Chevalier	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Yancopoulos	NULL
,	NULL
G.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
259	NULL
,	NULL
1736-1739	NULL
Hailman	NULL
,	NULL
E.	NULL
,	NULL
Lichenstein	NULL
,	NULL
H.	NULL
S.	NULL
,	NULL
Wurfel	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Miller	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Johnson	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Kelley	NULL
,	NULL
M.	NULL
,	NULL
Busse	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Zukowski	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Wright	NULL
,	NULL
S.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179	NULL
,	NULL
269-277	NULL

